% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-08-24}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1284.

\begin{enumerate}[leftmargin=*]
\item Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; Crossref]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Momi, D.; Nahas, Y.; Wyrick, D.; Marks, L. C.; Claar, L. D.; De Filippo, R.; Seyfourian, P.; Pizzagalli, D. A.; Buice, M.; Ott, T.; Koch, C.; Rembado, I. (2026). \textit{Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.14.744865}{doi:10.64898/2026.08.14.744865}.
\item Belle Buzzi (2026). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://doi.org/10.25772/0t5k-3r51}{doi:10.25772/0t5k-3r51}.
\item Bozkir, I. K.; Lashin, R.; Liu, T.; Pal, D.; Diba, K.; Kinsky, N. R. (2026). \textit{Psilocybin lengthens hippocampal sharp wave ripples}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.17.745042}{doi:10.64898/2026.08.17.745042}.
\item Clark Rachel N (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review}. Lynchburg Journal of Medical Science. [published; Crossref]. \href{https://doi.org/10.63932/3067-7106.1087}{doi:10.63932/3067-7106.1087}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin Administration With 5-HT1a Blockade}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565493}{source link}.
\item Brian Ross (2026). \textit{Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00517}{doi:10.1556/2054.2026.00517}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item Ke X, Du X, Wang X. (2026). \textit{Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03816-9}{doi:10.1038/s41380-026-03816-9}.
\item Kothiwala FM, Murphy RJ, Alshakhouri M, Douglass HM, Evans WJ, Paterson T, Muthukumaraswamy S, Sumner RL. (2026). \textit{An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.}. Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1159/pha/aejag002}{doi:10.1159/pha/aejag002}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item University Health Network, Toronto (2026). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Giovenzana M, Nicosia N, Spinosa S, Musazzi L, Mingardi J. (2026). \textit{Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.}. Pharmacological research. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2026.108366}{doi:10.1016/j.phrs.2026.108366}.
\item Chiu YT, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer KR, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2026). \textit{A suite of engineered mice for interrogating psychedelic drug actions.}. Nature neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-026-02375-0}{doi:10.1038/s41593-026-02375-0}.
\item Li, Z.; Weber, C.; Sellitti, F.; Simmler, L. D. (2026). \textit{Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.31.741703}{doi:10.64898/2026.07.31.741703}.
\item Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T (2026). \textit{Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00138}{doi:10.1021/acschemneuro.6c00138}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06001749}{source link}.
\item Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM. (2026). \textit{Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03801-2}{doi:10.1038/s41380-026-03801-2}.
\item Martin, H. M.; Cofre, R.; Destexhe, A. (2026). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item Frederik Gudmundsen, Julia Czurylo, Daniel Ryskamp Rijsketic, Camilla Trang Vo, Janika Ruuska, Naja S. Jessen, Sophie Woodruff, Christina Baun, Matthias M. Herth, Vladimir Shalgunov, Boris D. Heifets, Patrick M. Fisher, Mikael Palner (2026). \textit{Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-75890-0}{doi:10.1038/s41467-026-75890-0}.
\item Werle I, Probst MEC, Bertoglio LJ. (2026). \textit{Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.}. Journal of psychopharmacology (Oxford, England). [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261464979}{doi:10.1177/02698811261464979}.
\item Akbar Razeen J., Stringer Amy D., Wiah Sonita, Dachepalli Meghana, Daws Stephanie E., Inan Saadet, Rawls Scott M. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JEC, Dos Santos RG (2026). \textit{Classic psychedelics and personality: An updated systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.}. Hearing research. [published; PubMed]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Kareem Soliman (2026). \textit{Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/hba3y}{doi:10.17605/osf.io/hba3y}.
\item Jones GH, Gilbert JR, Johnston JN, Akula N, Schulmann A, Arakelian M, Peng S, Yuan P, Winful EA, Yavi M, Quintanilla B, Elkahloun A, Moaddel R, Henter ID, Greenstein D, Machado-Vieira R, Bartley CM, Kadriu B, Amit M, Rezvani K, Kvarta MD, McMahon FJ, Zarate CA (2026). \textit{Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03777-z}{doi:10.1038/s41380-026-03777-z}.
\item Fleury S, Chang LJ, Nautiyal KM. (2026). \textit{Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse models}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.24.740586}{doi:10.64898/2026.07.24.740586}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06299319}{source link}.
\item Torres Mc Cook, A. R.; Mimura, C. B.; Alvarez, L. D.; Liberman, A. C. (2026). \textit{Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic Evidence}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.24.740367}{doi:10.64898/2026.07.24.740367}.
\item Parr BA, Young WB, Silberstein SD (2026). \textit{Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2026.2706794}{doi:10.1080/14737175.2026.2706794}.
\item Tyler WJ, Sellers E, McDonnell MB. (2026). \textit{Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response Model}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.19.739440}{doi:10.64898/2026.07.19.739440}.
\item Cervera-Sanchez Miguel Benjamin, San-Juan Daniel, Díaz-Peregrino Roberto, Camacho-Castillo Evelin Zulema, Bringas-Ortiz Sthefany Anahi, Padilla-Cabezutd Christian (2026). \textit{Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations}. British Journal of Clinical Pharmacology. [published; Crossref]. \href{https://doi.org/10.1002/bcp.70690}{doi:10.1002/bcp.70690}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Savalia NK, Shao LX, Knox CA, Gilbert AD, Jiang Q, Kwan AC (2026). \textit{Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.16.738983}{doi:10.64898/2026.07.16.738983}.
\item Gattuso James J., Kamal Ahmed, Payet Jennyfer M., Havaux Kato, Hendey Jenna, Bezcioglu Bilgenur, Phelan Zoe J., Orchard Maddy, Bhanot Divyesh, Hale Matthew W., Hannan Anthony J., Renoir Thibault (2026). \textit{Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02501-3}{doi:10.1038/s41386-026-02501-3}.
\item Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka (2026). \textit{Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21406174}{doi:10.5281/zenodo.21406174}.
\item Diamond Therapeutics Inc. (2026). \textit{A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07710027}{source link}.
\item Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek (2026). \textit{Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.94.73071}{doi:10.12775/jehs.2026.94.73071}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Hidalgo Jiménez J, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03746-6}{doi:10.1038/s41380-026-03746-6}.
\item Khyber Medical University Peshawar (2026). \textit{Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07703722}{source link}.
\item Lin C, Wang X (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item Thomas CW, LaMalfa KS, Whelan TP, Blackmore T, Golden CT, Pizzagalli DA, Bergman J, Gilmour G, Kangas BD (2026). \textit{Psychedelics produce enduring enhancement of reward responsiveness in male rats.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02475-2}{doi:10.1038/s41386-026-02475-2}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Ottawa Hospital Research Institute (2026). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item Liu C, Ho EM, Enos AS, Baublyte UB, Luna IM, Kosche AR, Sohal VS (2026). \textit{Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.05.736652}{doi:10.64898/2026.07.05.736652}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item Baker JJ, Kogan E, Ma S, Lu J, Zuo Y (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Rosado Axel F., Yu Abigail L., Yang Jen-Hau, Rondeau Jocelyne, Floris Gabriele, Basu Aakash, Staszko Stephanie, Dibbs Mark, Feng Jiesi, Li Yulong, Warner-Schmidt Jennifer, Kelmendi Benjamin, Krystal John H., Pittenger Christopher, Kwan Alex C., Kaye Alfred P. (2026). \textit{α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice}. Molecular Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41380-026-03713-1}{doi:10.1038/s41380-026-03713-1}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Koning Elena, Richard Jérémie, Keshen Aaron (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions}. International Journal of Eating Disorders. [published; Crossref]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Pasquini Lorenzo, Vohryzek Jakub, Escrichs Anira, Perl Yonatan Sanz, Ponce-Alvarez Adrian, Idesis Sebastian, Girn Manesh, Roseman Leor, Mitchell Jennifer M., Gazzaley Adam, Kringelbach Morten, Nutt David J., Lyons Taylor, Carhart-Harris Robin L., Deco Gustavo (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits}. Human Brain Mapping. [published; Crossref]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Sabani Astrit, Khatak Adnan (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine \& Surgery. [published; Crossref]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Physical chemistry chemical physics: PCCP. [published; PubMed]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Allen Josh, Jupp Bianca, Baker Tamara L., Haskali Mohammad B., Brkljača Robert, Plummer Zoe, Sun Mujun, Brand Justin, Christie Brian R., Debert Chantel T., McDonald Stuart J., O’Brien Terence J., Casillas-Espinosa Pablo M., Shultz Sandy R. (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; Crossref]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Özaydın Y, Canlan Özaydın B (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM (2026). \textit{Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70138}{doi:10.1111/bph.70138}.
\item Fleury S, Nautiyal KM (2026). \textit{Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03488-5}{doi:10.1038/s41380-026-03488-5}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Escobar-Cornejo Guillermo, Corredor-Gamba Julián, Rodriguez-Rojas Yoly, Cárdenas F. P. (2026). \textit{The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin}. Revista de Neuro-Psiquiatría. [published; Crossref]. \href{https://doi.org/10.20453/rnp.v89i2.7539}{doi:10.20453/rnp.v89i2.7539}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item Seillier L, Seillier A, Zvolska MA, Šlamberová R (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item Johns Hopkins University (2026). \textit{Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06407635}{source link}.
\item Low ZXB (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Zhang T, Lin C, Wang X (2026). \textit{Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.6c00146}{doi:10.1021/acsptsci.6c00146}.
\item Barajas David A, Carter Heather C Noda, Tomedi Michael R, Lam Hiu Yu, Deloatch Tiffany N, Reynolds Gregory D, Castaneto Marisol S, Ke Pucheng (2026). \textit{Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bkag030}{doi:10.1093/jat/bkag030}.
\item Udoro AJ, Yukyi Y, Ansari AZ, Gandara HA, Ahmed F, Hunt D (2026). \textit{Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.110791}{doi:10.7759/cureus.110791}.
\item Patil Shivaputra A., Hunsberger Holly C. (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Mallaroni P, Singleton SP, Mason NL, Satterthwaite TD, Ramaekers JG (2026). \textit{Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03447-0}{doi:10.1038/s41380-026-03447-0}.
\item Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.}. Schizophrenia research. [published; PubMed]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Egger K, Bozsak R, Aicher HD, Sari H, Poetzsch SN, Rominger A, Martin-Soelch C, Smallridge JW, Dornbierer D, Quednow BB, Scheidegger M, Cumming P (2026). \textit{Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.}. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. [published; PubMed]. \href{https://doi.org/10.1177/0271678x261454172}{doi:10.1177/0271678x261454172}.
\item Houff Jenna, Williams Andrew, Allen Obie, Gisabella Barbara, Pantazopoulos Harry, Del Arco Alberto (2026). \textit{Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex}. European Journal of Neuroscience. [published; Crossref]. \href{https://doi.org/10.1111/ejn.70574}{doi:10.1111/ejn.70574}.
\item Hood Alex, Elkins Gary (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Brendstrup-Brix Kristoffer, Ozenne Brice, Fisher Patrick M., Stenbæk Dea S., Petersen Anja S., Armand Sophia, McCulloch Drummond E-Wen., Marstrand-Joergensen Maja Rou, Ulv Larsen Sara M., Johansen Annette, Jensen Rigmor H., Knudsen Gitte M., Madsen Martin K. (2026). \textit{Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261449380}{doi:10.1177/02698811261449380}.
\item Pei Gang (2026). \textit{A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox}. Cell Discovery. [published; Crossref]. \href{https://doi.org/10.1038/s41421-026-00906-4}{doi:10.1038/s41421-026-00906-4}.
\item Naja Bralic, Elena Bragagnolo, Mikael Palner (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Cavallaro N, Rai P, Akins D, Soltanpour S, Nasseef MT, Ortiz RJ, Utama R, Cody CR, Mistry A, Brenhouse HC, Kulkarni PP, Ferris CF (2026). \textit{Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.}. Neuroscience bulletin. [published; PubMed]. \href{https://doi.org/10.1007/s12264-026-01632-3}{doi:10.1007/s12264-026-01632-3}.
\item Conn K, Wong N, Sunnetci S, Al Siyabi A, McCoy K, Huang K, Greaves E, Milton LK, Kuhlmann L, Maguire S, Foldi CJ. (2026). \textit{Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.14.725265}{doi:10.64898/2026.05.14.725265}.
\item Yang KH, Rasmussen M, Bhatt K, Satybaldiyeva N, Kepner W, Moore AA, Bergstrom J (2026). \textit{Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2673845}{doi:10.1080/02791072.2026.2673845}.
\item Kwiatos N, Ossel S, Mutti FG (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item Signor Anna, Colognesi Martina, Finzi Giovanna, Gabbia Daniela, Mattarei Andrea, Comai Stefano, Pasut Gianfranco, Folli Franco, Manfredi Paolo, De Martin Sara (2026). \textit{SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models}. Journal of Hepatology. [published; Crossref]. \href{https://doi.org/10.1016/s0168-8278(26)01861-1}{doi:10.1016/s0168-8278(26)01861-1}.
\item Domi Ana, Lucente Erika, Cadeddu Davide, Bengtsson Niklas, Smedler Erik, Adermark Louise (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Moreno Francisco A., Allen Katja E., Wiegand Christopher B., Dunne Rajan, Prickett James I., Bayze Brian, Allen John J. B. (2026). \textit{A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261424214}{doi:10.1177/02698811261424214}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Gillet A, Geron C, Vitello MM, Lejeune N (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Silva MH (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.}. Birth defects research. [published; PubMed]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Cancer reports (Hoboken, N.J.). [published; PubMed]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Marini S, De Berardis D. (2026). \textit{The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1998.v1}{doi:10.20944/preprints202604.1998.v1}.
\item Schober S, Dorfmann L, Walther K, Blei F, Chadeayne AR, Gressler M, Bartram S, O'Connor SE, Hoffmeister D (2026). \textit{Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.70318}{doi:10.1002/cbic.70318}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Askey Tatum, Allen-Ross Daniel, Luzyanin Daniil, Lasrado Reena, Gilmour Gary, Hunt Stephen P., Tamagnini Francesco, Ahmed Maqsood, Stephens Gary J., Maiarú Maria (2026). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. Communications Biology. [published; Crossref]. \href{https://doi.org/10.1038/s42003-026-10065-7}{doi:10.1038/s42003-026-10065-7}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Yacoub J, Bray E, Bayyat J, Glatfelter GC, Leake A, Buitrago EM, Maitland AD, Partilla J, Cavalco NG, Schalk SS, Lammers JC, Baumann MH, McCorvy J, Leahy JW, Gulick D, Witowski CG, von Salm JL (2026). \textit{Serotonergic Polypharmacology of 2-Halogenated Tryptamines.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.16.718915}{doi:10.64898/2026.04.16.718915}.
\item Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao LX, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC (2026). \textit{Psilocybin reshapes cortical inhibition through selective interneuron recruitment.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.16.718963}{doi:10.64898/2026.04.16.718963}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Veysi A, Atanasovski D, Ardalan M, Motamed N, Eriksson E (2026). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Minauro-Sanmiguel F, Vargas-Perez H (2026). \textit{Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2026.02.028}{doi:10.1016/j.neuroscience.2026.02.028}.
\item Allen J, Sun M, Baker TL, Dames S, Kryskow P, Christie BR, McDonald SJ, Shultz SR (2026). \textit{Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03329-x}{doi:10.1038/s41380-025-03329-x}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS (2026). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Kazdan J, Ladha KS, Husain MI (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg (2026). \textit{Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00626-4}{doi:10.1038/s44220-026-00626-4}.
\item Maltman JL, González-Maeso J (2026). \textit{Reshaping human neurons.}. eLife. [published; PubMed]. \href{https://doi.org/10.7554/elife.110981}{doi:10.7554/elife.110981}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Schmidt Malin, Hoffrichter Anne, Davoudi Mahnaz, Horschitz Sandra, Lau Thorsten, Meinhardt Marcus W, Spanagel Rainer, Ladewig Julia, Köhr Georg, Koch Philipp (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. eLife. [published; Crossref]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Mäki-Marttunen Verónica (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors}. Communications Biology. [published; Crossref]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB (2026). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item J K Aronson (2026). \textit{When I use a word... The psychedelic mind’s eye}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.s548}{doi:10.1136/bmj.s548}.
\item Portes MAM, Bertoglio LJ (2026). \textit{Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2644865}{doi:10.1080/02791072.2026.2644865}.
\item Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL (2026). \textit{Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms27062811}{doi:10.3390/ijms27062811}.
\item Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D. (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; Crossref]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Wood BJ, Vest MF, Carfagno C, Bartley KR, Sharma P, Halberstadt AL, Blough BE, Murnane KS (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Chauhan SB, Akhtar N, Jain C, Singh I (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.}. CNS \& neurological disorders drug targets. [published; PubMed]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Stanley Kisourin (2026). \textit{Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18825289}{doi:10.5281/zenodo.18825289}.
\item Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS (2026). \textit{Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01256-7}{doi:10.1007/s40263-025-01256-7}.
\item Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Shokr MM, Fawzy MN, Abdelaziz AM (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Molecular and cellular neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Girault N, Quiroga L, Jedrecy S, Bertin S, Djonouma N, Fossati P (2026). \textit{[Perspectives opened up by the physiopathological understanding of psychiatric disorders].}. La Revue du praticien. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/41878960/}{source link}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item Gabriella Gobbi (2026). \textit{The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07433452}{source link}.
\item Garcia-Romeu Albert, Naudé Gideon P., Rebman Alison W., So Sara, Yaffe Abigail, Geithner Ian, Kozero Erica A., Yang Ting, Soloski Mark J., Aucott John N. (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease}. Scientific Reports. [published; Crossref]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Ishii M, Zervas M. (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; OpenAlex]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Murray Z, Lewies A, Wentzel JF, Schutte-Smith M, Erasmus E, Noreljaleel A, Visser H, Wilhelm A, Issahaku AR (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Renner AC, Kargbo RB (2026). \textit{Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00780}{doi:10.1021/acsmedchemlett.5c00780}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Bostancıklıoğlu M, Kaplan DS, Bal R, Yiğit E, Ulusal H, Temiz E (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Kramer HM, Hibicke M, Middleton J, Jaster AM, Kristensen JL, Nichols CD (2026). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M (2026). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M (2026). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Roser P (2026). \textit{[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].}. Therapeutische Umschau. Revue therapeutique. [published; PubMed]. \href{https://doi.org/10.23785/tu.2026.01.006}{doi:10.23785/tu.2026.01.006}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item de la Fuente Revenga M, González-Maeso J (2026). \textit{Snapshot IP Detection Following 5-HTA Receptor Stimulation in the Mouse Brain.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00932}{doi:10.1021/acschemneuro.5c00932}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Xia K, Gao T (2026). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. [published; PubMed]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Renner AC, Kargbo RB (2026). \textit{Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00714}{doi:10.1021/acsmedchemlett.5c00714}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item CA Madsen, M. Navarro, E. Kolesnik, D. Kazani, V. Shalgunov, M. Zabrocki, A. Nasser, D. Luethi, F. Holze, M.E. Liechti, S.S. Johansen, M.K.K. Nielsen, H.D. Hansen, G.M. Knudsen (2026). \textit{Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106824}{doi:10.1016/j.nsa.2025.106824}.
\item Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K (2026). \textit{Sex-dependent effects of psychedelics: review of evidence from rodent models.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1824073}{doi:10.3389/fpsyt.2026.1824073}.
\item Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti (2026). \textit{COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER}. Genetics and Molecular Research. [published; OpenAlex]. \href{https://doi.org/10.4238/e91xh631}{doi:10.4238/e91xh631}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2026). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček (2026). \textit{Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106393}{doi:10.1016/j.nsa.2025.106393}.
\item K. Aleksič (2026). \textit{The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106729}{doi:10.1016/j.nsa.2025.106729}.
\item M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek (2026). \textit{Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106823}{doi:10.1016/j.nsa.2025.106823}.
\item Holze F, Liechti ME, Müller F (2026). \textit{Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_510}{doi:10.1007/7854\_2024\_510}.
\item Higgins GA, MacMillan C, de Lannoy I, Tyler C, Slassi M (2026). \textit{Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251361453}{doi:10.1177/02698811251361453}.
\item Heal DJ, Gosden J, Smith SL (2026). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J (2026). \textit{A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251378512}{doi:10.1177/02698811251378512}.
\item Maltby CJ, Klein AK, Paschen E, Pinto J, Dvorak D, Hedde JR, Hanks AN, Bianchi M, Hughes ZA (2026). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Rasheed S, Arif R, Raza AA, Samadi A (2026). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.}. Annals of medicine and surgery (2012). [published; PubMed]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W (2026). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Spiti A, Caldirola D, Perna G (2026). \textit{New Antidepressant Development in the Treatment of Depression.}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA (2026). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Siwek L, Nowocien M, Balajewicz B, Samborska A, Szukalska S, Karczewska M, Lichwala K, Wróblewski K, Wróblewska P (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Habelt B (2026). \textit{The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2026.1779055}{doi:10.3389/fpsyg.2026.1779055}.
\item Geraci J, Viirre E, Qorri B, Pani L (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B (2026). \textit{Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002197}{doi:10.1097/jcp.0000000000002197}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C. (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2025). \textit{Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.22.696123}{doi:10.64898/2025.12.22.696123}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item Sophie Woodruff, Meghan Hibicke, Charles D. Nichols (2025). \textit{Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393186}{doi:10.1177/28314425251393186}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Renner AC, Kargbo RB (2025). \textit{Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00661}{doi:10.1021/acsmedchemlett.5c00661}.
\item Magee Sarah N., Sereno Allison C., Echeveste-Sanchez Maria, Shannon Elizabeth G., Mohsin Abir, Mott Sarah E., Faccidomo Sara P., Hodge Clyde W., Herman Melissa A. (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. The Journal of Neuroscience. [published; Crossref]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item Amin Reihani, Fatemeh Shaki (2025). \textit{Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22038/apjmt.2025.89401.1525}{doi:10.22038/apjmt.2025.89401.1525}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Dumenil M, Cordova G, El-Hage W (2025). \textit{[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2025.02.007}{doi:10.1016/j.encep.2025.02.007}.
\item Drewko AJ, Habets RLP, Brunt TM (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Inan S, Morris P, Rawls SM, Daws S (2025). \textit{Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.}. Behavioural pharmacology. [published; PubMed]. \href{https://doi.org/10.1097/fbp.0000000000000856}{doi:10.1097/fbp.0000000000000856}.
\item Kleditzsch N, Gattuso JJ, Hannan AJ, Renoir T (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item Domżalska M, Kwiatkowska J, Cichoń I, Sokołowska E (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Jaster AM, Hadlock TM, Buzzi B, Maltman JL, Silva GM, Saha S, Koseli E, Pondelick AM, Thakur N, Zhang X, Li G, Ledesma-Corvi S, Moore KN, Peterson HR, Fujita B, Zylko AL, Lewis MR, Poklis JL, Halquist MS, Wolstenholme JT, Selley DE, Hamilton PJ, Lu C, Damaj MI, González-Maeso J (2025). \textit{Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item University of Zurich (2025). \textit{Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06081179}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Zhang W, Hwang SY, Luther J (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Current gastroenterology reports. [published; PubMed]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Montgomery Tony, Grant DeMond M. (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration}. Advance. [preprint; Crossref]. \href{https://doi.org/10.31124/advance.175630073.36585408/v2}{doi:10.31124/advance.175630073.36585408/v2}.
\item Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis (2025). \textit{Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100004}{doi:10.1016/j.psyche.2025.100004}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Renner AC, Kargbo RB (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Thomas Zandonai, Sofia Venturini, Ornella Corazza (2025). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Hammo A, Wisser S, Cichon J (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ (2025). \textit{Psychedelic 5-HT receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-025-02069-z}{doi:10.1038/s41593-025-02069-z}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item Li R, Yan H, Chen Y, Liu Y, Tang L, Yu J, Liu J, Wang H, Wang S, Cheng J (2025). \textit{Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045}{doi:10.1021/acs.jmedchem.5c02045}.
\item special to C EN Mara Johnson-Groh (2025). \textit{Is there more to magic mushrooms than psilocybin?}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10322-feature2}{doi:10.1021/cen-10322-feature2}.
\item Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih, Bryan L. Roth, Sarah N. Magee, Evi Kostenis, Melissa A. Herman, Mia L. Foglesong (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/ce6e-4888}{doi:10.17615/ce6e-4888}.
\item Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595) (2025). \textit{Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045.s001}{doi:10.1021/acs.jmedchem.5c02045.s001}.
\item Douglas B. Craig (2025). \textit{Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers}. Insights in Chemistry and Biochemistry. [published; OpenAlex]. \href{https://doi.org/10.33552/icbc.2025.03.000562}{doi:10.33552/icbc.2025.03.000562}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item University of Washington (2025). \textit{A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06644170}{source link}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Arif Ersegün Kahraman (2025). \textit{Psilocybin as a Treatment for Depression}. University of Debrecen Electronic Archive. [published; OpenAlex]. \href{https://hdl.handle.net/2437/398317}{source link}.
\item Richardson B, Inserra A, Pileggi M, Prud'Homme T, Bruno V, Wan-Yan-Chan D, Shareghi-Ghahreman I, Nasini S, Strand T, Leyton M, Sonenberg N, De Gregorio D, Sprouse J, Bambico FR, Gobbi G (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Afrooghe Arya, Ahmadi Elham, Lesani Ali, Mehranjani Mahya Soleymani, Elahi Mohammad, Babaei Mohammadreza, Shayan Maryam, Shafaroodi Hamed, Jafari Razieh Mohammad, Foroumadi Alireza, Manavi Mohammad Amin, Dehpour Ahmad-Reza (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg's Archives of Pharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD (2025). \textit{Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-09671-y}{doi:10.1038/s41586-025-09671-y}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Poster Abstracts. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Hatzipantelis CJ, Liu M, Love A, Leventhal SJ, Maera H, Viswanathan S, Avetisyan E, Belinsky L, Rangel MM, Jain NJ, Kelly M, Copeland C, Khatib YA, Fiehn O, Olson DE, Stolzenberg DS (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari (2025). \textit{Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review}. Brazilian Journal of Science. [published; OpenAlex]. \href{https://doi.org/10.14295/bjs.v4i10.785}{doi:10.14295/bjs.v4i10.785}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon (2025). \textit{Trauma under psychedelics: how psychoactive substances impact trauma processing}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21363}{doi:10.1002/wps.21363}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Kargbo RB (2025). \textit{Therapeutic Divergence in 5-HTA Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Kaylee Reid, Daniel Kot, Argel Aguilar-Valles (2025). \textit{Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour}. Carleton undergraduate journal of science.. [published; OpenAlex]. \href{https://doi.org/10.22215/cujs.v5i1.5286}{doi:10.22215/cujs.v5i1.5286}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item McCoy K, Reed F, Conn K, Foldi CJ (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Physiology \& behavior. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Glenn DL, Choi SH, Zimmerman RS (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba Torres IT (2025). \textit{Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.92568}{doi:10.7759/cureus.92568}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Bilenker D, Avena NM (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Albert Garcia-Romeu (2025). \textit{Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics?}. NPP-Digital Psychiatry and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s44277-025-00043-y}{doi:10.1038/s44277-025-00043-y}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Madden MB, Schaefgen C, Vedak B, Kwon J, Pedra KSD, Sheats SH, Puche AC, Wolff SBE, Mathur BN (2025). \textit{Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item Mickaël Naassïla (2025). \textit{Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2025.05.064}{doi:10.1016/j.neuroscience.2025.05.064}.
\item B Richardson, M Pileggi, T Prud’Homme, D Wan-Yan-Chan, I Shareghi-Ghahreman, S Nasini, V Bruno, T Strand, M Leyton, N Sonenberg, D De Gregorio, J Sprouse, F Bambico, G Gobbi (2025). \textit{363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359530}{source link}.
\item Hashimoto K (2025). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Vinarcsik L, Smoller C, Grossberg G (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Drugs \& aging. [published; PubMed]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Fundamental \& clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz (2025). \textit{204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.019}{doi:10.1093/ijnp/pyaf052.019}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Bernard Lerer, Michal Brownstien, Mitchell A. Lazar, Peter A. Goldstein, Alexander Botvinnik, Alan P. Kozikowski, Tzuri Lifschytz (2025). \textit{551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.368}{doi:10.1093/ijnp/pyaf052.368}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Folia medica Cracoviensia. [published; PubMed]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P. (2025). \textit{Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7099164/v1}{doi:10.21203/rs.3.rs-7099164/v1}.
\item Rudy LM, Godlewski MM (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson (2025). \textit{Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.25.9.2091}{doi:10.1167/jov.25.9.2091}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Nathan H. Heller, Frederick Streeter Barrett, Tobias Buchborn, Daniel Collerton, David Dupuis, Adam L. Halberstadt, Renaud Jardri, Tehseen N. Noorani, Katrin H. Preller, John-Paul Taylor (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Cohen ZZ, Blest-Hopley G (2025). \textit{Females in Psychedelic Research: A Perspective for Advancing Research and Practice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00255}{doi:10.1021/acsptsci.5c00255}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Braekow Pauline, Neumann Joachim, Kirchhefer Uwe, Gergs Ulrich (2025). \textit{Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice}. Pharmaceuticals. [published; Crossref]. \href{https://doi.org/10.3390/ph18071009}{doi:10.3390/ph18071009}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison (2025). \textit{Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030022}{doi:10.3390/psychoactives4030022}.
\item Rahbarnia A, Li Z, Fletcher PJ (2025). \textit{Effects of psilocybin, the 5-HT receptor agonist TCB-2, and the 5-HT receptor antagonist M100907 on visual attention in male mice in the continuous performance test.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD (2025). \textit{5-HT receptors: Pharmacology and functional selectivity.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Wu Y, Ran J, Mo J, Wang J (2025). \textit{4-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.70063}{doi:10.1111/adb.70063}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL (2025). \textit{The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00208}{doi:10.1021/acsptsci.5c00208}.
\item Liu Yi-Fei, Lien-Chung Wei (2025). \textit{Advancing the Anthropology of Psychedelics: Integrating Clinical Evidence, Sociocultural Insights, and Ethical Frameworks}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.70004}{doi:10.1111/anoc.70004}.
\item Slot J, Hoffmeister D (2025). \textit{Psychedelic fungi.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2025.02.026}{doi:10.1016/j.cub.2025.02.026}.
\item Erkizia-Santamaría I, Martínez-Álvarez N, Salinas-Novoa L, Meana JJ, Ortega JE (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME (2025). \textit{Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.3618}{doi:10.1002/cpt.3618}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-08813-6}{doi:10.1038/s41586-025-08813-6}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Han C, Baek H, Lim JY, Kim E, Tran CK, Freeman E, Chen Z, Yoo SH, Burish MJ (2025). \textit{Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.}. The journal of headache and pain. [published; PubMed]. \href{https://doi.org/10.1186/s10194-025-02008-0}{doi:10.1186/s10194-025-02008-0}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Ritika Jagdeep Shah, Ashish Sarangi (2025). \textit{Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review}. Alcoholism Treatment Quarterly. [published; OpenAlex]. \href{https://doi.org/10.1080/07347324.2025.2500345}{doi:10.1080/07347324.2025.2500345}.
\item Jonathan A. Leighton, Carmen Lau, Aisha Savdo, L Granata (2025). \textit{Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series}. Cephalalgia Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/25158163251345472}{doi:10.1177/25158163251345472}.
\item Bagdasarian FA, Larsen K, Deng HP, Fisher PM, Mandeville JB, Sander CY, Wey HY, Hansen HD (2025). \textit{Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.}. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. [published; PubMed]. \href{https://doi.org/10.1177/0271678x241302937}{doi:10.1177/0271678x241302937}.
\item Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y, Halberstadt AL, Young JW (2025). \textit{Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110334}{doi:10.1016/j.neuropharm.2025.110334}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. European journal of anaesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Koseli E, Buzzi B, Honaker T, Rakholia Y, Lewis M, Gaines-Smith M, Jaster AM, Gonzalez-Maeso J, Damaj MI (2025). \textit{IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2025.107699}{doi:10.1016/j.phrs.2025.107699}.
\item Rockhill KM, Black JC, Iwanicki J, Abraham A (2025). \textit{Polysubstance Use Profiles Among the General Adult Population, United States, 2022.}. American journal of public health. [published; PubMed]. \href{https://doi.org/10.2105/ajph.2024.307979}{doi:10.2105/ajph.2024.307979}.
\item Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O (2025). \textit{Psilocybin for disorders of consciousness: A case-report study.}. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. [published; PubMed]. \href{https://doi.org/10.1016/j.clinph.2025.02.264}{doi:10.1016/j.clinph.2025.02.264}.
\item Pałasz A, Pukowiec M, Bogus K, Suszka-Świtek A, Filipczyk Ł, Mordecka-Chamera K, Worthington JJ, Sygidus M, Wojtas A, Bysiek A, Gołembiowska K (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Neurobiology of stress. [published; PubMed]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Lucia Centofanti, Stefano La Rosa, Giovanna Finzi, Franco Folli, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2025). \textit{FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(25)01632-0}{doi:10.1016/s0168-8278(25)01632-0}.
\item Jérémie Richard, Jeremy Scott, Sandeep M. Nayak, Nathan D. Sepeda, Matthew X. Lowe, Heather Jackson, Albert Garcia-Romeu (2025). \textit{Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-025-01489-z}{doi:10.1007/s11469-025-01489-z}.
\item McClure, Taylor, Krzywicki, AJ, Nathan, Jude, Kane, Jackson (2025). \textit{Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted Therapy}. Exhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University). [published; OpenAlex]. \href{https://www.exhibit.xavier.edu/curca/2025/schedule/48}{source link}.
\item Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V (2025). \textit{[Treatment with psychedelics: potential benefits in Parkinson's disease].}. Revue medicale suisse. [published; PubMed]. \href{https://doi.org/10.53738/revmed.2025.21.915.47180}{doi:10.53738/revmed.2025.21.915.47180}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM. (2025). \textit{Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647757}{doi:10.1101/2025.04.08.647757}.
\item Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2025). \textit{13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.250}{doi:10.1016/j.biopsych.2025.02.250}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Bysiek A, Wojtas A, Szpręgiel I, Wawrzczak-Bargieła A, Maćkowiak M, Gołembiowska K (2025). \textit{The effect of low-dose psilocybin on brain neurotransmission and rat behavior.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111347}{doi:10.1016/j.pnpbp.2025.111347}.
\item Nicholas Gregory, Tyler E. Girard, Akila Ram, Austen B. Casey, Robert C. Malenka, Vivianne L. Tawfik, Boris D. Heifets (2025). \textit{Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.104862}{doi:10.1016/j.jpain.2025.104862}.
\item Balabandian Mohammad, Manavi Mohammad Amin, Lesani Ali, Mohammad Jafari Razieh, Shafaroodi Hamed, Heidari Navid, Mirnajafi-Zadeh Javad, Foroumadi Alireza, Afrooghe Arya, Dehpour Ahmad Reza (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; Crossref]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item University Hospital, Basel, Switzerland (2025). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899334}{source link}.
\item Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C, Cameron M, Zahoruiko Y, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Portes MAM, Werle I, Bertoglio LJ (2025). \textit{Is there a place for psychedelics in sports practice?}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.13}{doi:10.1017/neu.2025.13}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Gattuso JJ, Wilson C, Li S, Hannan AJ, Renoir T (2025). \textit{Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.ejphar.2025.177304}{doi:10.1016/j.ejphar.2025.177304}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff (2025). \textit{Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2025.200301}{doi:10.1176/appi.ajp-rj.2025.200301}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Elmira Zolali, Mahfuz Sakib, Jenny L. Wilkerson, Lance Richard McMahon, Samuel Obeng (2025). \textit{Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2024.100843}{doi:10.1016/j.jpet.2024.100843}.
\item Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A (2025). \textit{Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.2024.143}{doi:10.1192/bjp.2024.143}.
\item Viohl Niklas, Hakami Zanjani Ali Asghar, Khandelia Himanshu (2025). \textit{Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα}. FEBS Letters. [published; Crossref]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Serretti A (2025). \textit{Anhedonia: Current and future treatments.}. PCN reports: psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Julia Wójcik, Kacper Wojciech Pamuła, Marcin Cholewa, Karolina Kinga Kantor, Julia Plewniok, Maria Partyka, Maciej Kuca, Karolina Jaglarz, Wiktoria Maria Szymańska, Maksymilian Janeczek (2025). \textit{BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW}. Health Problems of Civilization. [published; OpenAlex]. \href{https://doi.org/10.5114/hpc.2025.147763}{doi:10.5114/hpc.2025.147763}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Kargbo RB (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Lucido MJ, Dunlop BW (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard (2025). \textit{Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00375}{doi:10.1556/2054.2025.00375}.
\item A. Signor, Martina Colognesi, Daniela Gabbia, Ilaria Zanotto, Y. Frion-Herrera, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, M. Pappagallo, Paolo Manfredi, S. De Martin (2025). \textit{Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.134}{doi:10.1016/j.dld.2025.01.134}.
\item Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu (2025). \textit{BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyae059.584}{doi:10.1093/ijnp/pyae059.584}.
\item Myfanwy Graham, Wayne Hall, Rosalie Liccardo Pacula, David Hammond (2025). \textit{International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112089}{doi:10.1016/j.drugalcdep.2024.112089}.
\item Destiny Carbello, Tomáš Páleníček (2025). \textit{Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112090}{doi:10.1016/j.drugalcdep.2024.112090}.
\item Amanda L. Elmore, Marina Bolser, Matt Richey (2025). \textit{Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive Age}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111723}{doi:10.1016/j.drugalcdep.2024.111723}.
\item Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G (2025). \textit{Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2024.2445016}{doi:10.1080/14737175.2024.2445016}.
\item Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.10.632408}{doi:10.1101/2025.01.10.632408}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y (2025). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C (2025). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X (2025). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT receptor activation and psychedelic-like activity.}. European journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Liao C, O'Farrell E, Qalieh Y, Savalia NK, Girgenti MJ, Kwan KY, Kwan AC (2025). \textit{Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.01.04.631335}{doi:10.1101/2025.01.04.631335}.
\item Kelly TJ, Liu QS (2025). \textit{Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation.}. Psychedelics. [published; PubMed]. \href{https://doi.org/10.61373/pp024b.0019}{doi:10.61373/pp024b.0019}.
\item Siddhant Pusdekar (2025). \textit{Psilocybin rewires specific mouse cortical networks in lasting ways}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/pkim3530}{doi:10.53053/pkim3530}.
\item Koschützke, Leif (2025). \textit{Psychedelics induced modulation of motor recovery after stroke}. Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET. [published; OpenAlex]. \href{https://doi.org/10.17590/asr.0000411}{doi:10.17590/asr.0000411}.
\item Kostić Marina D., Nedić Jana, Dragojević Jovana S., Divac Vera M. (2025). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Book of Proceedings. [published; Crossref]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2025). \textit{Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v7isup.1031}{doi:10.51126/revsalus.v7isup.1031}.
\item Michal Brownstien (2025). \textit{Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105450}{doi:10.1016/j.nsa.2025.105450}.
\item Tess L. Veuthey, Prasad Shirvalkar (2025). \textit{Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordings}. Brain stimulation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.brs.2024.12.653}{doi:10.1016/j.brs.2024.12.653}.
\item Mile Jevtić (2025). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S (2025). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Molecular biotechnology. [published; PubMed]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Ramaekers JG, Reckweg JT, Mason NL (2025). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, Schneier F (2025). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.}. Psychedelics. [published; PubMed]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item Cumming P, Egger K, Knudsen GM (2025). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Vogt SB, Liechti ME (2025). \textit{Clinical pharmacology.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D (2025). \textit{Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Kinderlehrer DA (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D (2025). \textit{Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.c209}{doi:10.7759/cureus.c209}.
\item De Gasperi R, Perez Garcia G, Gama Sosa MA, Perez GM, Abutarboush R, Kawoos U, Hof PR, Zhu CW, Ahlers ST, Elder GA (2025). \textit{Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.}. Frontiers in neurology. [published; PubMed]. \href{https://doi.org/10.3389/fneur.2025.1594335}{doi:10.3389/fneur.2025.1594335}.
\item Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA (2025). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Adeyinka D, Forsyth D, Currie S, Faraone N (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.}. Frontiers in systems neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Eline Pottie, G.C. Glatfelter, M.H. Baumann, Christophe P. Stove (2024). \textit{Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2023.100109}{doi:10.1016/j.etdah.2023.100109}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Werle I, Bertoglio LJ (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Szpręgiel I, Bysiek A (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Arman Fard, Allison Cohen (2024). \textit{Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings}. Journal of Student Research. [published; OpenAlex]. \href{https://doi.org/10.47611/jsrhs.v13i4.7602}{doi:10.47611/jsrhs.v13i4.7602}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Ande Bagdasarian, Kristian Larsen, Patrick M. Fisher, Hanne D. Hansen, Hsiao-Ying Wey (2024). \textit{Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human Primates}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2024/1133}{doi:10.58530/2024/1133}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ (2024). \textit{Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.09.23.559145}{doi:10.1101/2023.09.23.559145}.
\item Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye (2024). \textit{Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024e.0034}{doi:10.61373/pp024e.0034}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Imperial College London (2024). \textit{PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06258031}{source link}.
\item Jeanblanc J, Bordy R, Fouquet G, Jeanblanc V, Naassila M (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.}. Brain: a journal of neurology. [published; PubMed]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2024). \textit{Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.11.02.621692}{doi:10.1101/2024.11.02.621692}.
\item Zhen Z, Sun X, Yuan S, Zhang J (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Ivan VE, Tomàs-Cuesta DP, Esteves IM, Luczak A, Mohajerani M, McNaughton BL, Gruber AJ (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Wiens Kennedy R., Brooks Noah A. H., Riar Ishvin, Greuel Bridget K., Lindhout Ivan A., Klegeris Andis (2024). \textit{Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner}. Molecules. [published; Crossref]. \href{https://doi.org/10.3390/molecules29215084}{doi:10.3390/molecules29215084}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.23.619763}{doi:10.1101/2024.10.23.619763}.
\item Mott, Sarah E., Clyde W. Hodge, Jessica L. Hoffman, Maria Echeveste Sanchez, Christian S. Rollison, Margaret W. High, Devin P. Effinger, Melissa A. Herman, Sarah N. Magee, Daniel Toedt, Sema G. Quadir (2024). \textit{Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/kg31-1v38}{doi:10.17615/kg31-1v38}.
\item Mallaroni P, Singleton P, Mason NL, Satterthwaite TD, Ramaekers JG. (2024). \textit{The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.22.619393}{doi:10.1101/2024.10.22.619393}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item de la Fuente Revenga M, González-Maeso J (2024). \textit{Snapshot of 5-HT receptor activation in the mouse brain via IP detection.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Yu SJ, Wu KJ, Wang YS, Bae E, Chianelli F, Bambakidis N, Wang Y (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke.}. BMC neuroscience. [published; PubMed]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Jones JA, McMurray MS (2024). \textit{Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.16466}{doi:10.1111/bph.16466}.
\item Doss MK, Mallaroni P, Mason NL, Ramaekers JG (2024). \textit{Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.06.008}{doi:10.1016/j.bpsc.2024.06.008}.
\item Shakir J, Pedicini M, Bullock BC, Hoen PW, Macias LK, Freiman J, Pletnikov MV, Tamashiro KLK, Cordner ZA (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A (2024). \textit{Psilocybin in pharmacotherapy of obsessive-compulsive disorder.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00633-1}{doi:10.1007/s43440-024-00633-1}.
\item Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. (2024). \textit{Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.09.24313316}{doi:10.1101/2024.09.09.24313316}.
\item Albert Garcia-Romeu (2024). \textit{Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.65789.rfs2023}{doi:10.1089/psymed.2024.65789.rfs2023}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T (2024). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Treviranus GRS (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Psychiatria Danubina. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39378462/}{source link}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Ask the expert - Psychedelic substances. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Charlotte Smith (2024). \textit{Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing}. Journal of Management Inquiry. [published; OpenAlex]. \href{https://doi.org/10.1177/10564926241267208}{doi:10.1177/10564926241267208}.
\item Frye MA, Singh B, Breitinger SA, Oesterle TS (2024). \textit{Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.24cr15378}{doi:10.4088/jcp.24cr15378}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2024). \textit{­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4947184/v1}{doi:10.21203/rs.3.rs-4947184/v1}.
\item William M. Campo, Ann Marie Yali (2024). \textit{Psychedelic use and psychological flexibility: The role of meaningful intention and decentering}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00350}{doi:10.1556/2054.2024.00350}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Rodolfo Myronn de Melo Rodrigues (2024). \textit{Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024c.0022}{doi:10.61373/pp024c.0022}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Kaiserman A, Vanderjist L, Kornreich C (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Psychiatria Danubina. [published; PubMed]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Viohl N, Zanjani AAH, Khandelia H. (2024). \textit{Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.23.604750}{doi:10.1101/2024.07.23.604750}.
\item Bagdasarian FA, Hansen HD, Chen J, Yoo CH, Placzek MS, Hooker JM, Wey HY (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item Anders Fink-Jensen, MD, DMSci (2024). \textit{Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04718792}{source link}.
\item DeBattista C, Schatzberg AF (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Psychopharmacology bulletin. [published; PubMed]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Shelby A. McGriff, Grant C. Glatfelter, David R. Manke, A.R. Chadeayne, Charles W. Schindler, Michaël Baumann (2024). \textit{Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110445}{doi:10.1016/j.drugalcdep.2023.110445}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item Neumann Joachim, Dimov Kiril, Azatsian Karyna, Hofmann Britt, Gergs Ulrich (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Casanova AF, Ort A, Smallridge JW, Preller KH, Seifritz E, Vollenweider FX (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD (2024). \textit{RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-,-diisopropyltryptamine.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.4c00058}{doi:10.1021/acschemneuro.4c00058}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B (2024). \textit{Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/yb2v-ca64}{doi:10.17615/yb2v-ca64}.
\item Sean M. Viña (2024). \textit{Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020019}{doi:10.3390/psychoactives3020019}.
\item Iorgu AM, Vasilescu AN, Pfeiffer N, Spanagel R, Mallien AS, Inta D, Gass P (2024). \textit{Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-023-01699-3}{doi:10.1007/s00406-023-01699-3}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Amrit Baral, Yue Pan, Alberto J. Caban Martinez, Paulo S. Pinheiro, WayWay M. Hlaing, Denise C. Vidot (2024). \textit{Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2024.42.16\_suppl.e22518}{doi:10.1200/jco.2024.42.16\_suppl.e22518}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM (2024). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Hugh McGovern, Nick Wellman, Brendan Hutchinson, Lena Oestreich, Samuel E Cooper, Gregory Fonzo, Manoj Doss (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Harari R, Chatterjee I, Getselter D, Elliott E (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item Rogers SA, Heller EA, Corder G (2024). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.02.04.578811}{doi:10.1101/2024.02.04.578811}.
\item M. Imad Damaj, Javier González-Maeso, Belle Buzzi (2024). \textit{The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.320.935210}{doi:10.1124/jpet.320.935210}.
\item N. Jones, John A. Razidlo, Zarmeen Zahid, Cody J. Wenthur (2024). \textit{Psilocybin-induced anxiolytic effects supported by transient elevation of corticosterone}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.337.128335}{doi:10.1124/jpet.337.128335}.
\item M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL (2024). \textit{Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/acs.jmedchem.4c00082}{doi:10.1021/acs.jmedchem.4c00082}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.04.592469}{doi:10.1101/2024.05.04.592469}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M (2024). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Naunyn-Schmiedeberg's archives of pharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Geyer MA (2024). \textit{A Brief Historical Overview of Psychedelic Research.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item Holze F, Singh N, Liechti ME, D'Souza DC (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Cell death discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Thomann Jan, Kolaczynska Karolina E., Stoeckmann Oliver V., Rudin Deborah, Vizeli Patrick, Hoener Marius C., Pryce Christopher R., Vollenweider Franz X., Liechti Matthias E., Duthaler Urs (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; Crossref]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM (2024). \textit{The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2024). \textit{The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.19.590212}{doi:10.1101/2024.04.19.590212}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Ann Kashmer Yu (2024). \textit{Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review}. Journal For International Medical Graduates. [published; OpenAlex]. \href{https://doi.org/10.56570/jimgs.v1i1.155}{doi:10.56570/jimgs.v1i1.155}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J (2024). \textit{[Psychedelic psychiatry].}. Lakartidningen. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/38572715/}{source link}.
\item Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS (2024). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Steward T (2024). \textit{Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.}. Trends in molecular medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.molmed.2023.12.001}{doi:10.1016/j.molmed.2023.12.001}.
\item Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.}. Ageing research reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Tap SC (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item M. Imad Damaj, Eda Köşeli, Belle Buzzi, Yogesh Rakholia, Melissa J. Lewis, Javier González-Maeso (2024). \textit{Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2024.01.093}{doi:10.1016/j.jpain.2024.01.093}.
\item David Nutt (2024). \textit{Psychedelics: reconnecting the brain to heal the mind}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_156}{doi:10.1042/bio\_2023\_156}.
\item Vandevelde M, Simoens A, Vandekerckhove B, Stevens C (2024). \textit{Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.}. RSC medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1039/d4md00043a}{doi:10.1039/d4md00043a}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F (2024). \textit{Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.12.006}{doi:10.1016/j.euroneuro.2023.12.006}.
\item Sekssaoui M, Bockaert J, Marin P, Bécamel C (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT receptor the unique player?}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Rouaud A, Calder AE, Hasler G (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Watford T, Masood N (2024). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Amarnani AD, Free MF, Baweja R (2024). \textit{Psilocybin and the Development of Serotonin Toxicity.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.23cr03648}{doi:10.4088/pcc.23cr03648}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Alison Knopf (2024). \textit{NIDA: Psilocybin mushroom seizures rose significantly}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.34037}{doi:10.1002/adaw.34037}.
\item Funk D, Araujo J, Slassi M, Lanthier J, Atkinson J, Feng D, Lau W, Lê A, Higgins GA (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Dirk Trauner, Kenny Calderon-Godinez (2024). \textit{Tryptamine Derivatives of Norpsilocin Induce Psychedelic-Like Responses in Mice}. Synfacts. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0043-1773080}{doi:10.1055/s-0043-1773080}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL (2024). \textit{Effects of DMT on mental health outcomes in healthy volunteers.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-53363-y}{doi:10.1038/s41598-024-53363-y}.
\item Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B (2024). \textit{Psychedelics and sexual functioning: a mixed-methods study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-49817-4}{doi:10.1038/s41598-023-49817-4}.
\item Fletcher PJ, Li Z, Ji XD, Lê AD (2024). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT receptor agonist TCB-2 in male DBA/2J mice.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item Reed F, Foldi CJ (2024). \textit{Do the therapeutic effects of psilocybin involve actions in the gut?}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2023.12.007}{doi:10.1016/j.tips.2023.12.007}.
\item De Filippo R, Schmitz D (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Norred MA, Zuschlag ZD, Hamner MB (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Gojani EG, Wang B, Li DP, Kovalchuk O, Kovalchuk I (2024). \textit{The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation.}. Genes. [published; PubMed]. \href{https://doi.org/10.3390/genes15020183}{doi:10.3390/genes15020183}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item University Hospital, Basel, Switzerland (2024). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04227756}{source link}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Javier González-Maeso (2024). \textit{Psychedelics for mental health: a biochemical perspective}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_161}{doi:10.1042/bio\_2023\_161}.
\item Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Duan W, Cao D, Wang S, Cheng J (2024). \textit{Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Chemical reviews. [published; PubMed]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Paula Pastor Muñoz (2024). \textit{Differential effects of psychedelics and classical antidepressants on TrkB dimerization and neurotrophic signalling}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/577777}{source link}.
\item Michael D. Alpert, Kelley C. O’Donnell, Casey A. Paleos, Evan Sola, Christopher S. Stauffer, Anne Catherine Wagner, Christopher R. Nicholas, Michael C. Mithoefer (2024). \textit{Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230665}{doi:10.1176/appi.ajp.20230665}.
\item Barajas, Carlos (2024). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item R.S. Treviranus, Gottfried (2024). \textit{RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?}. University of Zagreb University Computing Centre (SRCE). [published; OpenAlex]. \href{https://doi.org/10.24869/psyd.2024.134}{doi:10.24869/psyd.2024.134}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item Prosenjit Ghosh, Avinash Desousa (2024). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka (2024). \textit{Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104020}{doi:10.1016/j.nsa.2024.104020}.
\item Kolesnik E., Navarro M. López, Raval N.R., Ozenne B., Hansen H.D. (2024). \textit{Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2024.105133}{doi:10.1016/j.nsa.2024.105133}.
\item Gukasyan N, Narayan SK (2024). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Gonzales SAB, Alexopoulos C, Arkfeld DG (2024). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report.}. Current rheumatology reviews. [published; PubMed]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Heresco-Levy U, Lerer B (2024). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D (2024). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R (2024). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Ibi D (2024). \textit{[Up-to-Date on clinical and preclinical studies of psilocybin therapy].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Olivier B, Olivier JDA (2024). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM (2024). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U (2024). \textit{Effects of hallucinogenic drugs on the human heart.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1334218}{doi:10.3389/fphar.2024.1334218}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.}. American journal of therapeutics. [published; PubMed]. \href{https://doi.org/10.1097/mjt.0000000000001727}{doi:10.1097/mjt.0000000000001727}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.}. American journal of therapeutics. [published; PubMed]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Robinson CL, Fonseca ACG, Diejomaoh EM, D'Souza RS, Schatman ME, Orhurhu V, Emerick T (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.}. Journal of pain research. [published; PubMed]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Lerer E, Botvinnik A, Shahar O, Grad M, Blakolmer K, Shomron N, Lotan A, Lerer B, Lifschytz T (2024). \textit{Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1391412}{doi:10.3389/fphar.2024.1391412}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO (2024). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Zheng S, Ma R, Yang Y, Li G (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item Gobbi G (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Rucker J, Butler M, Hambleton S, Bird C, Seynaeve M, Cheema S, Campbell-Coker K, Maggio C, Dunbar F, Lambru G, Matharu M (2024). \textit{Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.14837}{doi:10.1111/head.14837}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Wojtas A, Gołembiowska K (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.}. Life (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item Caíque Gois Cardoso, Milena de Barros Viana (2023). \textit{Psychedelics and cognitive function: A systematic review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v12i14.44436}{doi:10.33448/rsd-v12i14.44436}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Ivana Turek (2023). \textit{Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin}. Medical Writing. [published; OpenAlex]. \href{https://doi.org/10.56012/tsen2260}{doi:10.56012/tsen2260}.
\item Wsół A (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A (2023). \textit{Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0035}{doi:10.1089/psymed.2023.0035}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A (2023). \textit{Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item 7450 Summit Cir, Davison, MI48423, Sarah Naher (2023). \textit{The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review}. Journal of Sociology Psychology \& Religious Studies. [published; OpenAlex]. \href{https://doi.org/10.53819/81018102t4217}{doi:10.53819/81018102t4217}.
\item Raj P, Rauniyar S, Sapkale B (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux (2023). \textit{Extended difficulties following the use of psychedelic drugs: A mixed methods study}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0293349}{doi:10.1371/journal.pone.0293349}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS. (2023). \textit{Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.19.563138}{doi:10.1101/2023.10.19.563138}.
\item Tyagi R, Saraf TS, Canal CE (2023). \textit{The Psychedelic,-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.3c00137}{doi:10.1021/acsptsci.3c00137}.
\item Kargbo RB (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega (2023). \textit{PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1097}{doi:10.1016/j.ibneur.2023.08.1097}.
\item Amanda E. Downey (2023). \textit{6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.666}{doi:10.1016/j.jaac.2023.07.666}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Kevin M. Gray, Paul E. Croarkin (2023). \textit{Psychedelics as Therapeutics: Research Advances and Implications for Practice}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.1001}{doi:10.1016/j.jaac.2023.07.1001}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Mitch Earleywine, Maha N. Mian, Joseph A. De Leo (2023). \textit{Expectancies for Subjective and Antidepressant Effects in Psilocybin Users}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678231194798}{doi:10.1177/00221678231194798}.
\item Milan Scheidegger (2023). \textit{Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05780216}{source link}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Chen Xue, Jing Li, Lisa Yu, Francesca Maule, Li-Mei Chang, Jonathan Gallant, David J. Press, Sheetal A. Raithatha, Jillian M. Hagel, Peter J. Facchini (2023). \textit{A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines}. Journal of Biological Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jbc.2023.105231}{doi:10.1016/j.jbc.2023.105231}.
\item Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff (2023). \textit{Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2023.190103}{doi:10.1176/appi.ajp-rj.2023.190103}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item Rakić V (2023). \textit{Psilocybin: The most effective moral bio-enhancer?}. Bioethics. [published; PubMed]. \href{https://doi.org/10.1111/bioe.13196}{doi:10.1111/bioe.13196}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. International clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R (2023). \textit{The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231190865}{doi:10.1177/02698811231190865}.
\item Kiilerich KF, Lorenz J, Scharff MB, Speth N, Brandt TG, Czurylo J, Xiong M, Jessen NS, Casado-Sainz A, Shalgunov V, Kjaerby C, Satała G, Bojarski AJ, Jensen AA, Herth MM, Cumming P, Overgaard A, Palner M (2023). \textit{Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02280-z}{doi:10.1038/s41380-023-02280-z}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Benjamin M. Ross, James T. Neill (2023). \textit{Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00264}{doi:10.1556/2054.2023.00264}.
\item Robinson GI, Li D, Wang B, Zahoruiko Y, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I (2023). \textit{Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb45080427}{doi:10.3390/cimb45080427}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Razidlo J, Banks MI, Wenthur CJ (2023). \textit{Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.3c00123}{doi:10.1021/acsptsci.3c00123}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M (2023). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Terri D’Arrigo (2023). \textit{Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.08.8.3}{doi:10.1176/appi.pn.2023.08.8.3}.
\item Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Rudzki S (2023). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military medicine. [published; PubMed]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Jorge Valdiviezo-Oña, Lizbeth Toscano-Molina, Juan Fernando Chávez, Jonathan Elias Herrera Criollo, Clara Paz (2023). \textit{Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review}. Advances in Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1080/18387357.2023.2235030}{doi:10.1080/18387357.2023.2235030}.
\item Jim Gilligan (2023). \textit{Leveraging psychedelic therapies for binge eating disorder}. Open Access Government. [published; OpenAlex]. \href{https://doi.org/10.56367/oag-039-10936}{doi:10.56367/oag-039-10936}.
\item Chernoff T, Kliger B, Venturini DH (2023). \textit{[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].}. Vertex (Buenos Aires, Argentina). [published; PubMed]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Scott R. Walker, Glenn A. Pullella, Matthew Piggott, Peter J. Duggan (2023). \textit{Introduction to the chemistry and pharmacology of psychedelic drugs}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23050}{doi:10.1071/ch23050}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Nick Zagorski (2023). \textit{Psychedelic Therapy Requires Enhanced Consent Discussions}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.46}{doi:10.1176/appi.pn.2023.07.7.46}.
\item Tylš Filip, Vejmola Čestmír, Koudelka Vlastimil, Piorecká Václava, Kadeřábek Lukáš, Bochin Marcel, Novák Tomáš, Kuchař Martin, Bendová Zdeňka, Brunovský Martin, Horáček Jiří, Pálení ček Tomáš (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA (2023). \textit{In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.adf8332}{doi:10.1126/sciadv.adf8332}.
\item Wulff AB, Nichols CD, Thompson SM (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen (2023). \textit{Psychedelics reopen the social reward learning critical period}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-023-06204-3}{doi:10.1038/s41586-023-06204-3}.
\item Kargbo RB (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Nkadimeng SM, Steinmann CM, Eloff JN. (2023). \textit{Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202306.0362.v1}{doi:10.20944/preprints202306.0362.v1}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item Meyer M, Slot J (2023). \textit{The evolution and ecology of psilocybin in nature.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, Antenucci L, Kot EF, Goncharuk SA, Kaurinkoski K, Kuutti M, Fred SM, Elsilä LV, Sakson S, Cannarozzo C, Diniz CRAF, Seiffert N, Rubiolo A, Haapaniemi H, Meshi E, Nagaeva E, Öhman T, Róg T, Kankuri E, Vilar M, Varjosalo M, Korpi ER, Permi P, Mineev KS, Saarma M, Vattulainen I, Casarotto PC, Castrén E (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Ort A, Smallridge JW, Sarasso S, Casarotto S, von Rotz R, Casanova A, Seifritz E, Preller KH, Tononi G, Vollenweider FX (2023). \textit{TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2023.106589}{doi:10.1016/j.isci.2023.106589}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item Catharine Carfagno, M Vest, Kevin S. Murnane, Kariann Lamon, Bo Jarrett Wood (2023). \textit{Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive Effects}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.122.192360}{doi:10.1124/jpet.122.192360}.
\item Eliza Milliken, Peter Galettis, Jenny Martin (2023). \textit{A review of psilocybin: chemistry, clinical uses and future research directions}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23010}{doi:10.1071/ch23010}.
\item Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat (2023). \textit{THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE}. PARIPEX-INDIAN JOURNAL OF RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.36106/paripex/6712845}{doi:10.36106/paripex/6712845}.
\item Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A (2023). \textit{Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.05.11.540409}{doi:10.1101/2023.05.11.540409}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS (2023). \textit{Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20220835}{doi:10.1176/appi.ajp.20220835}.
\item Ibi D (2023). \textit{[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ (2023). \textit{Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2023.03.031}{doi:10.1016/j.jpsychires.2023.03.031}.
\item Elisabeth Jean Wood (2023). \textit{Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin}. Vanderbilt Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.15695/vurj.v13i1.5403}{doi:10.15695/vurj.v13i1.5403}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item Glatfelter GC, Naeem M, Pham DNK, Golen JA, Chadeayne AR, Manke DR, Baumann MH (2023). \textit{Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy--dimethyltryptamine in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.2c00222}{doi:10.1021/acsptsci.2c00222}.
\item Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh, Teruki Koizumi, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.358}{doi:10.1016/j.biopsych.2023.02.358}.
\item Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier (2023). \textit{347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.587}{doi:10.1016/j.biopsych.2023.02.587}.
\item David Nutt (2023). \textit{Psychedelic Medicine: From Brain Science to Clinical Trials}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.022}{doi:10.1016/j.biopsych.2023.02.022}.
\item Jonah H. Shepherd, Caitlin Baten, Amanda M. Klassen, Gladys Zamora, Sarah Saravia, Elizabeth Pritchard, Zulaikha Ali, Saneh K. Kahlon, Kyla Whitelock, Fabiola A. Reyes, Dawson H. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.749}{doi:10.1016/j.biopsych.2023.02.749}.
\item Jianmeng Song, Yasaman Kambari, Aron Amaev, Fumihiko Ueno, Edgardo Torres Carmona, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111068}{doi:10.1016/j.mehy.2023.111068}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ (2023). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Neurochemical research. [published; PubMed]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Pain practice: the official journal of World Institute of Pain. [published; PubMed]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item University Hospital, Basel, Switzerland (2023). \textit{Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04849013}{source link}.
\item Domanegg K, Sommer WH, Meinhardt MW (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Antioxidants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Lee HJ, Stein MB (2023). \textit{Update on treatments for anxiety-related disorders.}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Heal DJ, Gosden J, Smith SL, Atterwill CK (2023). \textit{Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109375}{doi:10.1016/j.neuropharm.2022.109375}.
\item McTaggart AR, James TY, Slot JC, Barlow C, Fechner N, Shuey LS, Drenth A (2023). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Wang Jing, Liang Min, Shang Qing, Qian Hongyan, An Ran, Liu Hua, Shao Gaojie, Li Tao, Liu Xinshe (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; Crossref]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Hibicke M, Kramer HM, Nichols CD (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item J. H. Shepherd, C.T.M. Baten, A. C. Klassen, G. Zamora, Sarah Saravia, Elizabeth Pritchard, Ziad A. Ali, S. K. Kahlon, Kyla Whitelock, F. A. Reyes, D. W. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2023.1948}{doi:10.1192/j.eurpsy.2023.1948}.
\item Roberts BF, Zylko AL, Waters CE, Crowder JD, Gibbons WJ, Sen AK, Jones JA, McMurray MS (2023). \textit{Effect of psilocybin on decision-making and motivation in the healthy rat.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2022.114262}{doi:10.1016/j.bbr.2022.114262}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Terri D’Arrigo (2023). \textit{Psychedelics Legislation Gains Momentum}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.4}{doi:10.1176/appi.pn.2023.03.3.4}.
\item Ashish Sarangi, Omotola Akinkunmi (2023). \textit{Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease}. American Journal of Geriatric Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jagp.2022.12.201}{doi:10.1016/j.jagp.2022.12.201}.
\item Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D (2023). \textit{Considerations in assessing the abuse potential of psychedelics during drug development.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109352}{doi:10.1016/j.neuropharm.2022.109352}.
\item Gonda X, Dome P, Neill JC, Tarazi FI (2023). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Burmester DR, Madsen MK, Szabo A, Aripaka SS, Stenbæk DS, Frokjaer VG, Elfving B, Mikkelsen JD, Knudsen GM, Fisher PM (2023). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.}. Comprehensive psychoneuroendocrinology. [published; PubMed]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE (2023). \textit{5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.2c00718}{doi:10.1021/acschemneuro.2c00718}.
\item Jennings Hernandez (2023). \textit{Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health}. Advances in Research. [published; OpenAlex]. \href{https://doi.org/10.9734/air/2023/v24i1931}{doi:10.9734/air/2023/v24i1931}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item Dragana Marković, Eleonora Čapelja (2023). \textit{Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder}. AIDASCO Reviews. [published; OpenAlex]. \href{https://doi.org/10.59783/aire.2023.15}{doi:10.59783/aire.2023.15}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Kaden Venugopal, Nefissa Bedri (2023). \textit{The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.420}{doi:10.26685/urncst.420}.
\item Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2023). \textit{Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102665}{doi:10.1016/j.nsa.2023.102665}.
\item Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2023). \textit{Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102452}{doi:10.1016/j.nsa.2023.102452}.
\item Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc (2023). \textit{Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102939}{doi:10.1016/j.nsa.2023.102939}.
\item Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai (2023). \textit{Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103378}{doi:10.1016/j.nsa.2023.103378}.
\item Adriana D’Arienzo, Giorgio Samorini (2023). \textit{Italian psychedelic therapies of the past century: An historical overview}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231179687}{doi:10.1177/20503245231179687}.
\item Peter Hess (2023). \textit{Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/etcr6498}{doi:10.53053/etcr6498}.
\item John R. Rossiter (2023). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. (2023). \textit{Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2023.103662}{doi:10.1016/j.nsa.2023.103662}.
\item Knudsen GM (2023). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Johnston CB, Mangini M, Grob C, Anderson B (2023). \textit{The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.}. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jagp.2022.08.007}{doi:10.1016/j.jagp.2022.08.007}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ (2023). \textit{Mescaline: The forgotten psychedelic.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL (2023). \textit{Body mass index (BMI) does not predict responses to psilocybin.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221131994}{doi:10.1177/02698811221131994}.
\item Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V (2023). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Henningfield JE, Ashworth J, Heal DJ, Smith SL (2023). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Chen MH, Tu PC, Su TP (2023). \textit{Next generation antidepressants with novel mechanisms for treatment resistant depression.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.02.005}{doi:10.1016/bs.pbr.2023.02.005}.
\item Rivera-García MT, Cruz SL (2023). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. [published; PubMed]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Unzueta-Larrinaga P, Urigüen L (2023). \textit{Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response.}. Methods in molecular biology (Clifton, N.J.). [published; PubMed]. \href{https://doi.org/10.1007/978-1-0716-3307-6\_5}{doi:10.1007/978-1-0716-3307-6\_5}.
\item Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG (2023). \textit{Biological embedding of early trauma: the role of higher prefrontal synaptic strength.}. European journal of psychotraumatology. [published; PubMed]. \href{https://doi.org/10.1080/20008066.2023.2246338}{doi:10.1080/20008066.2023.2246338}.
\item Chen Y, Liu J, Yao Y, Yan H, Su R (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2023). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R (2023). \textit{Acute psilocybin increased cortical activities in rats.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item McIntyre RS (2023). \textit{Serotonin 5-HT receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2023.2248883}{doi:10.1080/14740338.2023.2248883}.
\item Abrams SK, Rabinovitch BS, Zafar R, Aziz AS, Cherup NP, McMillan DW, Nielson JL, Lewis EC (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.}. Neurotrauma reports. [published; PubMed]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item Lawrence DW (2023). \textit{Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.}. Innovations in clinical neuroscience. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37817818/}{source link}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Tasker NR, Pazur EJ, Wipf P (2023). \textit{Biological studies of clavine alkaloids targeting CNS receptors.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1286941}{doi:10.3389/fpsyt.2023.1286941}.
\item Waldbillig A, Baranova M, Neumann S, Andrade J, Sidhu S (2023). \textit{Exploring spp. mycelium and fruiting body chemistry for potential therapeutic compounds.}. Frontiers in fungal biology. [published; PubMed]. \href{https://doi.org/10.3389/ffunb.2023.1295223}{doi:10.3389/ffunb.2023.1295223}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Pędzich BD, Medrano M, Buckinx A, Smolders I, De Bundel D (2022). \textit{Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms232315284}{doi:10.3390/ijms232315284}.
\item O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP (2022). \textit{Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.}. Contemporary clinical trials. [published; PubMed]. \href{https://doi.org/10.1016/j.cct.2022.106976}{doi:10.1016/j.cct.2022.106976}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. 3 Biotech. [published; PubMed]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, Pittenger C (2022). \textit{Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.}. Heliyon. [published; PubMed]. \href{https://doi.org/10.1016/j.heliyon.2022.e12135}{doi:10.1016/j.heliyon.2022.e12135}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms232214148}{doi:10.3390/ijms232214148}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH (2022). \textit{Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.2c00177}{doi:10.1021/acsptsci.2c00177}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Natalie Gukasyan, Roland R. Griffiths, David Bryce Yaden, Denis Antoine, Sandeep M Nayak (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item Alison Knopf (2022). \textit{Psilocybin treatment for AUD: Promise in new study}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33584}{doi:10.1002/adaw.33584}.
\item Merlin Kirubakarababu, Arputharaj Samson Nesaraj (2022). \textit{Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective}. Indian Journal of Forensic Medicine \& Toxicology. [published; OpenAlex]. \href{https://doi.org/10.37506/ijfmt.v16i4.18608}{doi:10.37506/ijfmt.v16i4.18608}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A (2022). \textit{Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-022-33578-1}{doi:10.1038/s41467-022-33578-1}.
\item Natalie Gukasyan (2022). \textit{19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.664}{doi:10.1016/j.jaac.2022.07.664}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert opinion on drug discovery. [published; PubMed]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE (2022). \textit{Serotonin 5-HT, 5-HT and 5-HT receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Odland AU, Kristensen JL, Andreasen JT (2022). \textit{Animal Behavior in Psychedelic Research.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Goel DB, Zilate S (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Lerer B, Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2001983/v1}{doi:10.21203/rs.3.rs-2001983/v1}.
\item Doss MK, Barrett FS, Corlett PR (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item special to C EN Attabey Rodríguez Benítez (2022). \textit{Psychedelics’ binding depends on receptor mutations}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10031-scicon6}{doi:10.1021/cen-10031-scicon6}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Silveira Martins, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2022). \textit{P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2022.07.283}{doi:10.1016/j.toxlet.2022.07.283}.
\item Brian S. Barnett, Jeremy Weleff (2022). \textit{Psychedelics in the Treatment of Substance Use Disorders}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220804-01}{doi:10.3928/00485713-20220804-01}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2022.2297}{doi:10.1192/j.eurpsy.2022.2297}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H (2022). \textit{Magic mushroom extracts in lipid membranes.}. Biochimica et biophysica acta. Biomembranes. [published; PubMed]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Graham Zoe (2022). \textit{‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression}. Journal of High School Science. [published; Crossref]. \href{https://doi.org/10.64336/001c.37945}{doi:10.64336/001c.37945}.
\item Mark Molumby, Keith Gaynor, Suzanne Guérin, Róisín McNamara (2022). \textit{Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678221110331}{doi:10.1177/00221678221110331}.
\item Ken Garber (2022). \textit{Delix Therapeutics: psychedelics without the trip}. Nature Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1038/d41587-022-00006-0}{doi:10.1038/d41587-022-00006-0}.
\item Brian Peacock (2022). \textit{A-118 Psychedelic Interventions for Neuropsychological Conditions}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acac060.118}{doi:10.1093/arclin/acac060.118}.
\item Gumpper RH, Fay JF, Roth BL (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT serotonin receptors.}. Cell reports. [published; PubMed]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL (2022). \textit{Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.3281}{doi:10.1002/dta.3281}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.22.501026}{doi:10.1101/2022.07.22.501026}.
\item Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR (2022). \textit{Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.}. ACS omega. [published; PubMed]. \href{https://doi.org/10.1021/acsomega.2c03476}{doi:10.1021/acsomega.2c03476}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.13.498401}{doi:10.1101/2022.07.13.498401}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2022). \textit{Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.12.499688}{doi:10.1101/2022.07.12.499688}.
\item Bosch OG, Halm S, Seifritz E (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. International journal of bipolar disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Slocum ST, DiBerto JF, Roth BL (2022). \textit{Molecular insights into psychedelic drug action.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Smausz R, Neill J, Gigg J (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes, Renato Filev (2022). \textit{Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research}. Addiction Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.addicn.2022.100025}{doi:10.1016/j.addicn.2022.100025}.
\item Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T (2022). \textit{Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.}. Journal of personalized medicine. [published; PubMed]. \href{https://doi.org/10.3390/jpm12061004}{doi:10.3390/jpm12061004}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J (2022). \textit{Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item McClure-Begley TD, Roth BL (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Nature reviews. Drug discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA (2022). \textit{Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic engineering communications. [published; PubMed]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Invited speakers. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M (2022). \textit{Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph19116619}{doi:10.3390/ijerph19116619}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Neurology international. [published; PubMed]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan (2022). \textit{The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/2666082218666220513142002}{doi:10.2174/2666082218666220513142002}.
\item Stephan Schleim (2022). \textit{Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2022.906487}{doi:10.3389/fpsyt.2022.906487}.
\item Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann (2022). \textit{Receptor binding profiles and behavioral effects of psilocybin analogs}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2022.36.s1.r3639}{doi:10.1096/fasebj.2022.36.s1.r3639}.
\item Sotille R, Singh H, Weisman A, Vida T (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye (2022). \textit{P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.686}{doi:10.1016/j.biopsych.2022.02.686}.
\item Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS (2022). \textit{Models of psychedelic drug action: modulation of cortical-subcortical circuits.}. Brain: a journal of neurology. [published; PubMed]. \href{https://doi.org/10.1093/brain/awab406}{doi:10.1093/brain/awab406}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item Davoudian PA, Shao L, Kwan AC. (2022). \textit{Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.03.18.484437}{doi:10.1101/2022.03.18.484437}.
\item Benjamin Hearn, Michael D. Brubaker, George B. Richardson (2022). \textit{Counselors’ attitudes toward psychedelics and their use in therapy}. Journal of Counseling \& Development. [published; OpenAlex]. \href{https://doi.org/10.1002/jcad.12429}{doi:10.1002/jcad.12429}.
\item Amrutha Garimella, Bradley Kerr, Reese H. Hyzer, Megan A. Moreno (2022). \textit{184. Hallucinogens on TikTok}. Journal of Adolescent Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jadohealth.2022.01.101}{doi:10.1016/j.jadohealth.2022.01.101}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.28.482395}{doi:10.1101/2022.02.28.482395}.
\item Gass P, Vasilescu AN, Inta D (2022). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Current treatment options in oncology. [published; PubMed]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Bethany Halford﻿ (2022). \textit{Hallucinogen chemistry guides antidepressant drug discovery}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10005-leadcon}{doi:10.1021/cen-10005-leadcon}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item James Bailey Sanford (2022). \textit{Psychedelics hold promise for primary care research}. Family Practice. [published; OpenAlex]. \href{https://doi.org/10.1093/fampra/cmac009}{doi:10.1093/fampra/cmac009}.
\item Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100335}{doi:10.1016/j.nsa.2022.100335}.
\item A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska (2022). \textit{Neurochemical properties of psilocybin in comparison to ketamine in vivo}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100408}{doi:10.1016/j.nsa.2022.100408}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega (2022). \textit{Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100407}{doi:10.1016/j.nsa.2022.100407}.
\item Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček (2022). \textit{The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100948}{doi:10.1016/j.nsa.2022.100948}.
\item K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček (2022). \textit{The role of psilocybin in memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100953}{doi:10.1016/j.nsa.2022.100953}.
\item Daisuke Ibi (2022). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Jeff Tarrant (2022). \textit{SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?}. Biofeedback. [published; OpenAlex]. \href{https://doi.org/10.5298/1081-5937-50.03.03}{doi:10.5298/1081-5937-50.03.03}.
\item Daisuke Ibi (2022). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item Josh Nagra (2022). \textit{Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03}{source link}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL (2022). \textit{Psychedelics and health behaviour change.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM (2022). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Leger RF, Unterwald EM (2022). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2022). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS (2022). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Flanagan TW, Nichols CD (2022). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW (2022). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Huang J, Pham M, Panenka WJ, Honer WG, Barr AM (2022). \textit{Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.891512}{doi:10.3389/fpsyt.2022.891512}.
\item Vorobyeva N, Kozlova AA (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Roseman L, Preller KH, Fotiou E, Winkelman MJ (2022). \textit{Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.979764}{doi:10.3389/fphar.2022.979764}.
\item Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS (2022). \textit{Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.948729}{doi:10.3389/fpsyg.2022.948729}.
\item Alper K, Cange J, Sah R, Schreiber-Gregory D, Sershen H, Vinod KY (2022). \textit{Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.1074633}{doi:10.3389/fphar.2022.1074633}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2022). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris (2021). \textit{P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.335}{doi:10.1016/j.euroneuro.2021.10.335}.
\item A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue (2021). \textit{P.0623 The clinical relevance of the pharmacokinetics of psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.588}{doi:10.1016/j.euroneuro.2021.10.588}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J (2021). \textit{Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms222312995}{doi:10.3390/ijms222312995}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH (2021). \textit{Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.}. Cerebral cortex (New York, N.Y.: 1991). [published; PubMed]. \href{https://doi.org/10.1093/cercor/bhab202}{doi:10.1093/cercor/bhab202}.
\item Aleksandrova LR, Phillips AG (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Matt T. Keener (2021). \textit{6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2021.07.052}{doi:10.1016/j.jaac.2021.07.052}.
\item Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E (2021). \textit{A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab040}{doi:10.1093/ijnp/pyab040}.
\item Pascal Kintz, Jean-Sébastien Raul, Alice Ameline (2021). \textit{Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitations}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2021.100364}{doi:10.1016/j.forc.2021.100364}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir (2021). \textit{The therapeutical role of psychedelic drugs in treatment of mental disorders}. Bulletin of Integrative Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.36219/bpi.2021.3.09}{doi:10.36219/bpi.2021.3.09}.
\item Benjamin R. Lewis, Kevin Byrne (2021). \textit{Is MDD the right target for early-stage psychedelic-assisted therapy trials?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00180}{doi:10.1556/2054.2021.00180}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia (2021). \textit{Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?}. Revista Portuguesa de Psiquiatria e Saúde Mental. [published; OpenAlex]. \href{https://doi.org/10.51338/rppsm.2021.v7.i3.241}{doi:10.51338/rppsm.2021.v7.i3.241}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Waters K (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. Journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Chong Siew Koon, Tuan Sharipah binti Tuan Hadi, Izatt Syafieq bin Abd Rashad, Ruzila binti Ali (2021). \textit{A Case Series Describing the Tale of ‘The Magic Mushroom’; An Increasing Trend of Psychedelic Misuse Among Substance Abusers in Terengganu}. Malaysian Journal of Psychiatry. [published; OpenAlex]. \href{https://openalex.org/W3186346443}{source link}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić (2021). \textit{Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-021-00385-5}{doi:10.1007/s40429-021-00385-5}.
\item Philipp Matteo Härter (2021). \textit{The Influence of Psychedelic Drugs on the 'Sense of Self'}. Maastricht Student Journal of Psychology and Neuroscience. [published; OpenAlex]. \href{https://openjournals.maastrichtuniversity.nl/MSJPN/article/view/661}{source link}.
\item Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire (2021). \textit{Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa}. OBM Neurobiology. [published; OpenAlex]. \href{https://doi.org/10.21926/obm.neurobiol.2102102}{doi:10.21926/obm.neurobiol.2102102}.
\item Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B. (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/emcxw}{doi:10.31234/osf.io/emcxw}.
\item Luisa Prochazkova, Michiel van Elk, Josephine Marschall, Ben David Rifkin, George Fejer, Neil Schoen, Donatella Fiacchino, Martin Kuchar, Bernhard Hommel (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/emcxw\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V (2021). \textit{Psychedelic science in post-COVID-19 psychiatry.}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2021). \textit{LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.05.14.444193}{doi:10.1101/2021.05.14.444193}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Madison Hagood (2021). \textit{Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.}. Arizona State University Repository. [published; OpenAlex]. \href{https://repository.asu.edu/items/63943}{source link}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Katrin H. Preller (2021). \textit{Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.036}{doi:10.1016/j.biopsych.2021.02.036}.
\item University Hospital, Basel, Switzerland (2021). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03604744}{source link}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio (2021). \textit{O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n2-395}{doi:10.34119/bjhrv4n2-395}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Jeffrey A. Lieberman (2021). \textit{Back to the Future - The Therapeutic Potential of Psychedelic Drugs}. New England Journal of Medicine. [published; OpenAlex]. \href{https://doi.org/10.1056/nejme2102835}{doi:10.1056/nejme2102835}.
\item Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL (2021). \textit{Investigation of the Structure-Activity Relationships of Psilocybin Analogues.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.0c00176}{doi:10.1021/acsptsci.0c00176}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Bottemanne H, Claret A, Fossati P (2021). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Savalia NK, Shao LX, Kwan AC (2021). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Trends in neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Stenbæk DS, Madsen MK, Ozenne B, Kristiansen S, Burmester D, Erritzoe D, Knudsen GM, Fisher PM (2021). \textit{Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120959609}{doi:10.1177/0269881120959609}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Musikaphongsakul Prinya, Ya Kimheang, Subsoontorn Pakpoom, Lohitnavy Manupat (2021). \textit{Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans}. F1000Research. [published; Crossref]. \href{https://doi.org/10.12688/f1000research.28133.1}{doi:10.12688/f1000research.28133.1}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Odland AU, Kristensen JL, Andreasen JT (2021). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan (2021). \textit{Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.20ac13787}{doi:10.4088/jcp.20ac13787}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item R. Andrew Yockey, Keith A. King (2021). \textit{Use of psilocybin (“mushrooms”) among US adults: 2015-2018}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00159}{doi:10.1556/2054.2020.00159}.
\item Gotvaldová K, Hájková K, Borovička J, Jurok R, Cihlářová P, Kuchař M (2021). \textit{Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.2950}{doi:10.1002/dta.2950}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Michael W. Dzierlenga (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Harmony I. Risca (2021). \textit{Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety}. Western Michigan University ScholarWorks. [published; OpenAlex]. \href{https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777\&context=dissertations}{source link}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC (2021). \textit{Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1007/s13311-020-00962-y}{doi:10.1007/s13311-020-00962-y}.
\item Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM (2021). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Inserra A, De Gregorio D, Gobbi G (2021). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Higgins GA, Sellers EM (2021). \textit{5-HT and 5-HT receptors as potential targets for the treatment of nicotine use and dependence.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2021.01.007}{doi:10.1016/bs.pbr.2021.01.007}.
\item Castro Santos H, Gama Marques J (2021). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Porto biomedical journal. [published; PubMed]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Winkelman MJ (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. Risk management and healthcare policy. [published; PubMed]. \href{https://doi.org/10.2147/rmhp.s300656}{doi:10.2147/rmhp.s300656}.
\item Lugo-Radillo A, Cortes-Lopez JL (2021). \textit{Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1849879}{doi:10.1080/02791072.2020.1849879}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Rodríguez Arce JM, Winkelman MJ (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Khan FI, Hassan F, Lai D (2021). \textit{Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.}. Frontiers in immunology. [published; PubMed]. \href{https://doi.org/10.3389/fimmu.2021.794780}{doi:10.3389/fimmu.2021.794780}.
\item Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF (2021). \textit{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.}. Frontiers in neuroergonomics. [published; PubMed]. \href{https://doi.org/10.3389/fnrgo.2021.784576}{doi:10.3389/fnrgo.2021.784576}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G (2021). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Strickland JC, Garcia-Romeu A, Johnson M. (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f5dmt}{doi:10.31234/osf.io/f5dmt}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL (2020). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Smigielski L, Kometer M, Scheidegger M, Stress C, Preller KH, Koenig T, Vollenweider FX (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt (2020). \textit{MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00906-2}{doi:10.1038/s41386-020-00906-2}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch (2020). \textit{The Role of Psychedelics and Counseling in Mental Health Treatment}. Journal of Mental Health Counseling. [published; OpenAlex]. \href{https://doi.org/10.17744/mehc.42.4.03}{doi:10.17744/mehc.42.4.03}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Agata Tadeja (2020). \textit{Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.}. Farmacja Polska. [published; OpenAlex]. \href{https://doi.org/10.32383/farmpol/127922}{doi:10.32383/farmpol/127922}.
\item Shevaugn Johnson, Quentin Black (2020). \textit{Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-020-00398-7}{doi:10.1007/s11469-020-00398-7}.
\item Barrett FS, Krimmel SR, Griffiths RR, Seminowicz DA, Mathur BN (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, Stämpfli P, Seifritz E, Repovš G, Krystal JH, Murray JD, Anticevic A, Vollenweider FX (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Abbott KL, Gill KS, Flannery PC, Boothe DM, Dhanasekaran M, Pondugula SR (2020). \textit{Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.0c00241}{doi:10.1021/acschemneuro.0c00241}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (2020). \textit{Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2019.107933}{doi:10.1016/j.neuropharm.2019.107933}.
\item Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G (2020). \textit{Dynamic coupling of whole-brain neuronal and neurotransmitter systems.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1921475117}{doi:10.1073/pnas.1921475117}.
\item Morten Hesse (2020). \textit{Klassiske psykedeliske stoffer - inkl. psilocybin og LSD}. Patienthåndbogen. [published; OpenAlex]. \href{https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd}{source link}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Nutt D, Erritzoe D, Carhart-Harris R (2020). \textit{Psychedelic Psychiatry's Brave New World.}. Cell. [published; PubMed]. \href{https://doi.org/10.1016/j.cell.2020.03.020}{doi:10.1016/j.cell.2020.03.020}.
\item Madsen MK, Fisher PM, Stenbæk DS, Kristiansen S, Burmester D, Lehel S, Páleníček T, Kuchař M, Svarer C, Ozenne B, Knudsen GM (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item Sherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, Meisenheimer P (2020). \textit{Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.}. Journal of natural products. [published; PubMed]. \href{https://doi.org/10.1021/acs.jnatprod.9b01061}{doi:10.1021/acs.jnatprod.9b01061}.
\item Lewis CR, Preller KH, Braden BB, Riecken C, Vollenweider FX (2020). \textit{Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines8020034}{doi:10.3390/biomedicines8020034}.
\item Maho Hirasawa (2020). \textit{Effects of psilocin on the striatal monoamine contents in mice and rats}. The Pharmaceutical Society of Japan. [published; OpenAlex]. \href{https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail}{source link}.
\item Heidi Bush (2020). \textit{Psychedelic therapy: Fresh promise for mental health}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.32207}{doi:10.1002/mhw.32207}.
\item Case Medical Research (2020). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04227756}{doi:10.31525/ct1-nct04227756}.
\item Michael Draper (2020). \textit{Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America}. Journal of the History of Medicine and Allied Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/jhmas/jraa002}{doi:10.1093/jhmas/jraa002}.
\item Case Medical Research (2020). \textit{Repeat Dosing of Psilocybin in Migraine Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04218539}{doi:10.31525/ct1-nct04218539}.
\item Courtney Hutchison, Sara Bressi (2020). \textit{Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments}. Clinical Social Work Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10615-019-00743-x}{doi:10.1007/s10615-019-00743-x}.
\item Courtney Ledford (2020). \textit{Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/altreu\_projects/5}{source link}.
\item Ammar Jawad (2020). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt (2020). \textit{Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324520942345}{doi:10.1177/2050324520942345}.
\item Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers (2020). \textit{Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519900068}{doi:10.1177/2050324519900068}.
\item Germann CB (2020). \textit{The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.109406}{doi:10.1016/j.mehy.2019.109406}.
\item Dos Santos RG, Hallak JEC (2020). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Ho JT, Preller KH, Lenggenhager B (2020). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Rosalind Watts, Jason B. Luoma (2019). \textit{The use of the psychological flexibility model to support psychedelic assisted therapy}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.12.004}{doi:10.1016/j.jcbs.2019.12.004}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item Case Medical Research (2019). \textit{Psilocybin-assisted Psychotherapy for Opioid Use Disorder}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04161066}{doi:10.31525/ct1-nct04161066}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Chris Letheby (2019). \textit{The Varieties of Psychedelic Epistemology}. UWA Profiles and Research Repository (University of Western Australia). [published; OpenAlex]. \href{https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289}{source link}.
\item Case Medical Research (2019). \textit{Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04141501}{doi:10.31525/ct1-nct04141501}.
\item Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E (2019). \textit{Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2019.06.053}{doi:10.1016/j.neuroimage.2019.06.053}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers (2019). \textit{Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users}. Contemporary Drug Problems. [published; OpenAlex]. \href{https://doi.org/10.1177/0091450919863899}{doi:10.1177/0091450919863899}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019). \textit{Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119857204}{doi:10.1177/0269881119857204}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Jefsen O, Højgaard K, Christiansen SL, Elfving B, Nutt DJ, Wegener G, Müller HK (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Doreen M. Lewis (2019). \textit{Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments}. Addictive Disorders \& Their Treatment. [published; OpenAlex]. \href{https://doi.org/10.1097/adt.0000000000000178}{doi:10.1097/adt.0000000000000178}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS (2019). \textit{Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000253}{doi:10.1037/pha0000253}.
\item Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M. (2019). \textit{Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-019-0324-9}{doi:10.1038/s41386-019-0324-9}.
\item Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M. (2019). \textit{Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-019-0360-5}{doi:10.1038/s41386-019-0360-5}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR (2019). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Stenbaek DS, Kristiansen S, Burmester D, Madsen MK, Frokjaer VG, Knudsen GM, Fisher PM (2019). \textit{Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.24511}{doi:10.1002/hbm.24511}.
\item Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento (2019). \textit{New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-019-00249-z}{doi:10.1007/s40429-019-00249-z}.
\item McKenna Silva (2019). \textit{Attitudes Toward Medical Psychedelics}. Dominican Scholar (Dominican University of California). [published; OpenAlex]. \href{https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83}{source link}.
\item Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols (2019). \textit{Psychedelics Improve the Mental Health of Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2019.33.1\_supplement.666.1}{doi:10.1096/fasebj.2019.33.1\_supplement.666.1}.
\item Jenna Varley (2019). \textit{Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.005}{doi:10.1556/2054.2019.005}.
\item Ahmed Al-Imam, Faris Lami (2019). \textit{One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip}. Modern Applied Science. [published; OpenAlex]. \href{https://doi.org/10.5539/mas.v13n3p13}{doi:10.5539/mas.v13n3p13}.
\item William G. Crane (2019). \textit{Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality}. Furman University Scholar Exchange (Furman University). [published; OpenAlex]. \href{https://scholarexchange.furman.edu/furmanengaged/2019/all/522}{source link}.
\item P. Dürler (2019). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL (2019). \textit{Rapid-acting antidepressants.}. Advances in pharmacology (San Diego, Calif.). [published; PubMed]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD (2019). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Current molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Corne R, Mongeau R (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Biologie aujourd'hui. [published; PubMed]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW (2019). \textit{Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00955}{doi:10.3389/fpsyt.2019.00955}.
\item Madsen M.K., Burmester D., Stenbæk D.S., Kristiansen S., Dyssegaard A., Lehel S., Linnet K., Johansen S.S., Svarer C., Ozenne B., Erritzøe D., Fisher P.M., Knudsen G.M. (2019). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Di Giovanni G, De Deurwaerdère P (2018). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Jalal B (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Nichols DE (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC (2018). \textit{Psychedelics and Personality.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Elizabeth M. Nielson, Jeffrey Guss (2018). \textit{The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2018.009}{doi:10.1556/2054.2018.009}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Nicole Fossos-Wong, Ha-Yoon Lee, Kathryn B. Vincent, Devon Alisa Abdallah, Krista S. Dashtestani, M. Dolores Cimini, Karen L. Sokolowski, Geetha Subramaniam, Irene M. Geisner (2018). \textit{1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and Consequences}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2018.09.029}{doi:10.1016/j.jaac.2018.09.029}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Horsley Rachel R., Páleníček Tomáš, Kolin Jan, Valeš Karel (2018). \textit{Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000394}{doi:10.1097/fbp.0000000000000394}.
\item Flanagan TW, Nichols CD (2018). \textit{Psychedelics as anti-inflammatory agents.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Whelan A, Johnson MI (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Pain management. [published; PubMed]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein (2018). \textit{T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2018.02.600}{doi:10.1016/j.biopsych.2018.02.600}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC (2018). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.}. Evolution letters. [published; PubMed]. \href{https://doi.org/10.1002/evl3.42}{doi:10.1002/evl3.42}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Mascha M.J. Linszen, Hidde Kleijer, Iris E. Sommer (2018). \textit{Visual hallucinations and lifetime use of hallucinogen perception persisting disorder associated recreational drugs: results from a large online survey}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2017.12.114}{doi:10.1016/j.euroneuro.2017.12.114}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T (2018). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ (2018). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Camila Sanz, Federico Zamberlán, Earth Erowid, Fire Erowid, Enzo Tagliazucchi (2018). \textit{The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2018.00007}{doi:10.3389/fnins.2018.00007}.
\item Kayla Wilwohl (2018). \textit{Are psychedelics effective in treating anxiety associated with a lifethreatening disease}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/308}{source link}.
\item Kometer M, Vollenweider FX (2018). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2018). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2018). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Bogenschutz MP, Ross S (2018). \textit{Therapeutic Applications of Classic Hallucinogens.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD (2018). \textit{The Effects of Hallucinogens on Gene Expression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J (2018). \textit{Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Canal CE (2018). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Handbook of experimental pharmacology. [published; PubMed]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Vigerelli H, Sciani JM, Eula MAC, Sato LA, Antoniazzi MM, Jared C, Pimenta DC (2018). \textit{Biological Effects and Biodistribution of Bufotenine on Mice.}. BioMed research international. [published; PubMed]. \href{https://doi.org/10.1155/2018/1032638}{doi:10.1155/2018/1032638}.
\item Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A (2018). \textit{Psychedelics, Meditation, and Self-Consciousness.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2018.01475}{doi:10.3389/fpsyg.2018.01475}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S (2018). \textit{Rapid-Acting Antidepressants.}. Current pharmaceutical design. [published; PubMed]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Landon M. Klein (2017). \textit{If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/3bx3d6pf}{source link}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV (2017). \textit{Psychedelic Drugs in Biomedicine.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX (2017). \textit{Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2017.07.020}{doi:10.1016/j.neuroimage.2017.07.020}.
\item Ahmed Al-Imam (2017). \textit{Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User}. Global Journal of Health Science. [published; OpenAlex]. \href{https://doi.org/10.5539/gjhs.v9n11p168}{doi:10.5539/gjhs.v9n11p168}.
\item Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX (2017). \textit{Effect of Psilocybin on Empathy and Moral Decision-Making.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyx047}{doi:10.1093/ijnp/pyx047}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2017). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/176347}{doi:10.1101/176347}.
\item Janis Phelps (2017). \textit{Developing Guidelines and Competencies for the Training of Psychedelic Therapists}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817711304}{doi:10.1177/0022167817711304}.
\item Anne Walley (2017). \textit{The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish}. Student Research Proceedings. [published; OpenAlex]. \href{https://journals.macewan.ca/studentresearch/article/view/1171}{source link}.
\item Stephen Bright, M.L. Williams, David Caldicott (2017). \textit{Should addiction researchers be interested in psychedelic science?}. Drug and Alcohol Review. [published; OpenAlex]. \href{https://doi.org/10.1111/dar.12544}{doi:10.1111/dar.12544}.
\item Jonathan Nash (2017). \textit{The Development and Regulation of Psychedelic Medicines}. Northumbria Research Link (Northumbria University). [published; OpenAlex]. \href{http://nrl.northumbria.ac.uk/id/eprint/31696/1/SLSA.pptx}{source link}.
\item Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols (2017). \textit{Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.31.1\_supplement.820.4}{doi:10.1096/fasebj.31.1\_supplement.820.4}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR (2017). \textit{Psilocybin for treating substance use disorders?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Nichols DE, Johnson MW, Nichols CD (2017). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Huestis MA, Tyndale RF (2017). \textit{Designer Drugs 2.0.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.575}{doi:10.1002/cpt.575}.
\item Keli A. Herr (2017). \textit{Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats}. ScholarWorks - WMU (Western Michigan University). [published; OpenAlex]. \href{https://scholarworks.wmich.edu/dissertations/3170}{source link}.
\item Johnson MW, Garcia-Romeu A, Griffiths RR (2017). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.3109/00952990.2016.1170135}{doi:10.3109/00952990.2016.1170135}.
\item Mahapatra A, Gupta R (2017). \textit{Role of psilocybin in the treatment of depression.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Thomas K, Malcolm B, Lastra D (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2017). \textit{LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2017.00814}{doi:10.3389/fphar.2017.00814}.
\item Roseman L, Nutt DJ, Carhart-Harris RL (2017). \textit{Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2017.00974}{doi:10.3389/fphar.2017.00974}.
\item Daniel J, Haberman M (2017). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. The mental health clinician. [published; PubMed]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Celia J. A. Morgan, Amy McAndrew, Tobias Stevens, David Nutt, Will Lawn (2016). \textit{Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use}. Current Opinion in Behavioral Sciences. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cobeha.2016.10.009}{doi:10.1016/j.cobeha.2016.10.009}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček (2016). \textit{Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31133-6}{doi:10.1016/s0924-977x(16)31133-6}.
\item O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2016). \textit{Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31070-7}{doi:10.1016/s0924-977x(16)31070-7}.
\item Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz (2016). \textit{Psilocybin as an alternative medicine for patients suffering from depression}. Psychiatria i Psychologia Kliniczna. [published; OpenAlex]. \href{https://doi.org/10.15557/pipk.2016.0023}{doi:10.15557/pipk.2016.0023}.
\item William A. Richards (2016). \textit{Psychedelic Psychotherapy: Insights From 25 Years of Research}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816670996}{doi:10.1177/0022167816670996}.
\item Cornel N. Stanciu, Thomas M. Penders (2016). \textit{Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case}. Current Psychiatry Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573400512999160803102947}{doi:10.2174/1573400512999160803102947}.
\item Rickli A, Moning OD, Hoener MC, Liechti ME (2016). \textit{Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2016.05.001}{doi:10.1016/j.euroneuro.2016.05.001}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Howland RH (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Journal of psychosocial nursing and mental health services. [published; PubMed]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201633131}{doi:10.1002/chin.201633131}.
\item Tylš Filip, Páleníček Tomáš, Kadeřábek Lukáš, Lipski Michaela, Kubešová Anna, Horáček Jiří (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.506}{doi:10.1093/ijnp/pyw041.506}.
\item Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016). \textit{Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1524187113}{doi:10.1073/pnas.1524187113}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2016.03.007}{doi:10.1016/j.tet.2016.03.007}.
\item Nichols DE (2016). \textit{Psychedelics.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Suzuki K (2016). \textit{[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].}. Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/27255023/}{source link}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Joseph Havens (2016). \textit{MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://www.jstor.org/stable/1384511}{source link}.
\item Dimitria Electra Gatzia, Berit Brogaard (2016). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX (2016). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. NeuroImage. Clinical. [published; PubMed]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Shebloski KL, Broadway JM (2016). \textit{Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2016.00736}{doi:10.3389/fpsyg.2016.00736}.
\item Spain Aisling, Howarth Clare, Khrapitchev Alexandre A., Sharp Trevor, Sibson Nicola R., Martin Chris (2015). \textit{Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain}. Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.neuropharm.2015.07.018}{doi:10.1016/j.neuropharm.2015.07.018}.
\item Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson (2015). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1130}{doi:10.1016/j.drugalcdep.2015.07.1130}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2015). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Archives of toxicology. [published; PubMed]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Wiltshire PE, Hawksworth DL, Edwards KJ (2015). \textit{Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.}. Journal of forensic and legal medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.jflm.2015.05.010}{doi:10.1016/j.jflm.2015.05.010}.
\item Zhuk Olga, Jasicka-Misiak Izabela, Poliwoda Anna, Kazakova Anastasia, Godovan Vladlena, Halama Marek, Wieczorek Piotr (2015). \textit{Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice}. Toxins. [published; Crossref]. \href{https://doi.org/10.3390/toxins7041018}{doi:10.3390/toxins7041018}.
\item D.J. Nutt (2015). \textit{5HT2a Receptors - a New Target for Depression?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30027-4}{doi:10.1016/s0924-9338(15)30027-4}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30017-1}{doi:10.1016/s0924-9338(15)30017-1}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Halberstadt AL (2015). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS (2015). \textit{Recreational use, analysis and toxicity of tryptamines.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Sakashita Yuichi, Abe Kenji, Katagiri Nobuyuki, Kambe Toshie, Saitoh Toshiaki, Utsunomiya Iku, Horiguchi Yoshie, Taguchi Kyoji (2015). \textit{Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats}. Biological \textasciicircum{}|\textasciicircum{} Pharmaceutical Bulletin. [published; Crossref]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Ben Sessa (2014). \textit{Turn on and tune in to evidence-based psychedelic research}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(14)00120-5}{doi:10.1016/s2215-0366(14)00120-5}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX (2014). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral cortex (New York, N.Y.: 1991). [published; PubMed]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (2014). \textit{Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114548296}{doi:10.1177/0269881114548296}.
\item Franck Vandermoere, Philippe Marin (2014). \textit{Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization}. Receptors \& Clinical Investigation. [published; OpenAlex]. \href{https://doi.org/10.14800/rci.230}{doi:10.14800/rci.230}.
\item Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2014). \textit{P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(14)70316-5}{doi:10.1016/s0924-977x(14)70316-5}.
\item Ron Cole-Turner (2014). \textit{ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12110}{doi:10.1111/zygo.12110}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Rafael G. dos Santos (2014). \textit{Psychedelics, Glutamate, and Neuroimaging Studies}. Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.1097/aln.0000000000000243}{doi:10.1097/aln.0000000000000243}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& cellular proteomics: MCP. [published; PubMed]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Tylš F, Páleníček T, Horáček J (2014). \textit{Psilocybin--summary of knowledge and new perspectives.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D (2014). \textit{The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2014.00020}{doi:10.3389/fnhum.2014.00020}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Wilcox JA (2014). \textit{Psilocybin and Obsessive Compulsive Disorder.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2014.963754}{doi:10.1080/02791072.2014.963754}.
\item Tomáš Páleníček, Filip Tylš, M. Fujáková, Anna Kubešová, Pavlína Nováková, L. Kadeřábek, Martin Brunovský, Jiřı́ Horáček (2013). \textit{EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)77609-6}{doi:10.1016/s0924-9338(14)77609-6}.
\item Javier González-Maeso (2013). \textit{EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)78457-3}{doi:10.1016/s0924-9338(14)78457-3}.
\item Charlesice Hawkins (2013). \textit{Literature review: Considerations for Psychedelic Research}. UC Merced Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/m451020759}{doi:10.5070/m451020759}.
\item Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ (2013). \textit{Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbs117}{doi:10.1093/schbul/sbs117}.
\item Halberstadt AL, Geyer MA (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Deepak Prabhakar (2013). \textit{Exposure to Potent Hallucinogens in an Adolescent}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.13l01552}{doi:10.4088/pcc.13l01552}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J (2013). \textit{Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.}. Experimental brain research. [published; PubMed]. \href{https://doi.org/10.1007/s00221-013-3579-0}{doi:10.1007/s00221-013-3579-0}.
\item Kometer M, Schmidt A, Jäncke L, Vollenweider FX (2013). \textit{Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.3007-12.2013}{doi:10.1523/jneurosci.3007-12.2013}.
\item Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J (2013). \textit{Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2012.12.053}{doi:10.1016/j.neulet.2012.12.053}.
\item Hanks JB, González-Maeso J (2013). \textit{Animal models of serotonergic psychedelics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Michael Kometer, André Schmidt, Lutz Jäncke, Franz X. Vollenweider (2013). \textit{Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations}. Open MIND. [published; OpenAlex]. \href{https://openalex.org/W6929930661}{source link}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F (2013). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Brogaard B (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Ümit Sayın (2012). \textit{A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2012.10.2.528}{doi:10.14704/nq.2012.10.2.528}.
\item Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen (2012). \textit{Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'}. Netherlands Journal of Critical Care. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/9641390d-ba9e-4cf0-a1d5-445ec0f4717b}{source link}.
\item Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig, Mohamed El-Ounsi, Nicholas Capezio, Andrew J. Freeman, Ari Davis, Allan V. Kalueff (2012). \textit{Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.26.1\_supplement.1043.3}{doi:10.1096/fasebj.26.1\_supplement.1043.3}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX (2012). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012). \textit{Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2011.228}{doi:10.1038/npp.2011.228}.
\item LI Yu-bai (2012). \textit{Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model}. Zhongguo Yike Daxue xuebao. [published; OpenAlex]. \href{https://en.cnki.com.cn/Article\_en/CJFDTOTAL-ZGYK201201019.htm}{source link}.
\item David Luke, Devin B. Terhune, Ross Friday (2012). \textit{Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia}. Seeing and Perceiving. [published; OpenAlex]. \href{https://doi.org/10.1163/187847612x646956}{doi:10.1163/187847612x646956}.
\item Sumnall HR, Measham F, Brandt SD, Cole JC (2011). \textit{Salvia divinorum use and phenomenology: results from an online survey.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110385596}{doi:10.1177/0269881110385596}.
\item Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011). \textit{Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110388326}{doi:10.1177/0269881110388326}.
\item Halberstadt AL, Geyer MA (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX (2011). \textit{The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2010.10.002}{doi:10.1016/j.biopsych.2010.10.002}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson (2010). \textit{Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0014074}{doi:10.1371/journal.pone.0014074}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Thiago Berti Kirsten, Maria Martha Bernardi (2010). \textit{Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice}. Revista Brasileira de Farmacognosia. [published; OpenAlex]. \href{https://doi.org/10.1590/s0102-695x2010000300017}{doi:10.1590/s0102-695x2010000300017}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie (2010). \textit{The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series}. Cephalalgia. [published; OpenAlex]. \href{https://doi.org/10.1177/0333102410363490}{doi:10.1177/0333102410363490}.
\item O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider (2010). \textit{Psilocybin slows binocular rivalry switching through serotonin modulation}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/6.6.43}{doi:10.1167/6.6.43}.
\item Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider (2010). \textit{Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/5.8.683}{doi:10.1167/5.8.683}.
\item Matthew J. Baggott (2009). \textit{Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/7409s4th}{source link}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A (2009). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. International journal of cardiology. [published; PubMed]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G (2009). \textit{GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.}. Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.apradiso.2008.12.007}{doi:10.1016/j.apradiso.2008.12.007}.
\item González-Maeso J, Sealfon SC (2009). \textit{Agonist-trafficking and hallucinogens.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD (2009). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Kovacic P, Somanathan R (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative medicine and cellular longevity. [published; PubMed]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item J.C. Winter (2008). \textit{Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1356-8}{doi:10.1007/s00213-008-1356-8}.
\item Geyer MA, Vollenweider FX (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item Bray JK, Goddard WA (2008). \textit{The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.}. Journal of molecular graphics \& modelling. [published; PubMed]. \href{https://doi.org/10.1016/j.jmgm.2008.02.006}{doi:10.1016/j.jmgm.2008.02.006}.
\item F.X. Vollenweider, Daniel Hell, Michael Kometer (2008). \textit{Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ijpsycho.2008.05.397}{doi:10.1016/j.ijpsycho.2008.05.397}.
\item Danuta Marona-Lewicka, Benjamin R. Chemel, David E. Nichols (2008). \textit{Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1238-0}{doi:10.1007/s00213-008-1238-0}.
\item Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Wojciech Kostowski, W Rewerski, T Piechocki (2008). \textit{II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats}. Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1159/000136297}{doi:10.1159/000136297}.
\item González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008). \textit{Identification of a serotonin/glutamate receptor complex implicated in psychosis.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/nature06612}{doi:10.1038/nature06612}.
\item Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008). \textit{Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.09.007}{doi:10.1016/j.pbb.2007.09.007}.
\item Winter JC (2008). \textit{Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.07.007}{doi:10.1016/j.pbb.2007.07.007}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Marona-Lewicka D, Nichols DE (2007). \textit{Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.06.001}{doi:10.1016/j.pbb.2007.06.001}.
\item Winter JC, Rice KC, Amorosi DJ, Rabin RA (2007). \textit{Psilocybin-induced stimulus control in the rat.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.06.003}{doi:10.1016/j.pbb.2007.06.003}.
\item Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB (2007). \textit{The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1301324}{doi:10.1038/sj.npp.1301324}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Veniero Gambaro, Lucia Dell’Acqua, P.F. Croci, CM Pecoraro (2007). \textit{HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis}. Meeting on Recent Developments in Pharmaceutical Analysis. [published; OpenAlex]. \href{https://air.unimi.it/handle/2434/146135}{source link}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A (2007). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Annales Academiae Medicae Stetinensis. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/20143700/}{source link}.
\item Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006). \textit{Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.v67n1110}{doi:10.4088/jcp.v67n1110}.
\item Kelly Morris (2006). \textit{Hallucinogen research inspires “neurotheology”}. The Lancet Neurology. [published; OpenAlex]. \href{https://doi.org/10.1016/s1474-4422(06)70541-5}{doi:10.1016/s1474-4422(06)70541-5}.
\item David L. Eldridge, Karin Hillenbrand (2006). \textit{Hallucinogens}. Pediatrics in Review. [published; OpenAlex]. \href{https://doi.org/10.1542/pir.27.8.314}{doi:10.1542/pir.27.8.314}.
\item Jensen N, Gartz J, Laatsch H (2006). \textit{Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2006-931576}{doi:10.1055/s-2006-931576}.
\item Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX. (2006). \textit{Effects of psilocybin on time perception and temporal control of behaviour in humans.}. Queensland's institutional digital repository (The University of Queensland). [published; Europe PMC]. \href{https://doi.org/10.1177/0269881106065859}{source link}.
\item M. Braden, James J. Chambers, David E. Nichols (2006). \textit{Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.20.4.a247-c}{doi:10.1096/fasebj.20.4.a247-c}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Sławomir Majdanik, Piotr Waloszczyk, Małgorzata Piasecka, Tomasz Janus, E. Jasionowicz-Piatek, Mirosław Parafiniuk (2006). \textit{Psilocin multiple intake resulted and in cardiotoxic effects}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-f39ab4e7-0a77-47a4-b535-5656f3d5df88}{source link}.
\item Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He, Louis Shuster (2005). \textit{SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.200602219}{doi:10.1002/chin.200602219}.
\item Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA (2005). \textit{Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/s-2005-916185}{doi:10.1055/s-2005-916185}.
\item Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L (2005). \textit{SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.}. Bioorganic \& medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1016/j.bmcl.2005.06.104}{doi:10.1016/j.bmcl.2005.06.104}.
\item Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX (2005). \textit{Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.}. Journal of cognitive neuroscience. [published; PubMed]. \href{https://doi.org/10.1162/089892905774597191}{doi:10.1162/089892905774597191}.
\item Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren (2005). \textit{Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2005-918695}{doi:10.1055/s-2005-918695}.
\item Ben Sessa (2005). \textit{Can psychedelics have a role in psychiatry once again?}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.186.6.457}{doi:10.1192/bjp.186.6.457}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX (2004). \textit{Psilocybin impairs high-level but not low-level motion perception.}. Neuroreport. [published; PubMed]. \href{https://doi.org/10.1097/00001756-200408260-00023}{doi:10.1097/00001756-200408260-00023}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds}. Queensland's institutional digital repository (The University of Queensland). [published; OpenAlex]. \href{https://openalex.org/W111026355}{source link}.
\item Leon Gussow (2003). \textit{Designer Hallucinogens}. Emergency Medicine News. [published; OpenAlex]. \href{https://doi.org/10.1097/00132981-200312000-00015}{doi:10.1097/00132981-200312000-00015}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\item Anna Machoy-Mokrzyńska, Krzysztof Safranow, Krzysztof Borowiak, Sławomir Majdanik, Violetta Dziedziejko, Monika Białecka, Dariusz Chlubek (2003). \textit{The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-8e3dbd92-615e-497e-af12-c98c681b8b63}{source link}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek (2003). \textit{Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30}{source link}.
\item O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A\&2A agonist psilocybin on binocular rivalry rate and rhythmicity}. Social Neuroscience. [published; OpenAlex]. \href{https://espace.library.uq.edu.au/view/UQ:161618}{source link}.
\item Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R (2003). \textit{Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1300005}{doi:10.1038/sj.npp.1300005}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Rabin RA, Regina M, Doat M, Winter JC (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Umbricht D, Koller R, Vollenweider FX, Schmid L (2002). \textit{Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0006-3223(01)01242-2}{doi:10.1016/s0006-3223(01)01242-2}.
\item Fukuda K (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Vollenweider FX (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Dialogues in clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Brain research bulletin. [published; PubMed]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item Moldavan MG, Grodzinskaya AA, Solomko EF, Lomberh ML, Wasser SP, Storozhuk VM (2001). \textit{The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.}. Fiziolohichnyi zhurnal (Kiev, Ukraine: 1994). [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11962085/}{source link}.
\item Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE (2000). \textit{Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/jm000339w}{doi:10.1021/jm000339w}.
\item Barrett SP, Archambault J, Engelberg MJ, Pihl RO (2000). \textit{Hallucinogenic drugs attenuate the subjective response to alcohol in humans.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}{doi:10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}.
\item Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller (2000). \textit{177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0006-3223(00)00439-x}{doi:10.1016/s0006-3223(00)00439-x}.
\item M. G. Moldavan, Elvira F. Solomko, Anna A. Grodzínskaya, V. М. Storozhuk, Margarita Lomberg (2000). \textit{Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v2.i4.130}{doi:10.1615/intjmedmushr.v2.i4.130}.
\item McBride MC (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE (1999). \textit{Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/jm990325u}{doi:10.1021/jm990325u}.
\item Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999). \textit{5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(98)00108-0}{doi:10.1016/s0893-133x(98)00108-0}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D (1998). \textit{Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.}. Neuroreport. [published; PubMed]. \href{https://doi.org/10.1097/00001756-199812010-00024}{doi:10.1097/00001756-199812010-00024}.
\item Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, B. Thelen, Hiltrud Lindenblatt, K.-A. Kovar, H. Sass, M.A. Geyer (1998). \textit{529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0167-8760(98)90528-1}{doi:10.1016/s0167-8760(98)90528-1}.
\item Vollenweider FX (1998). \textit{Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-979353}{doi:10.1055/s-2007-979353}.
\item Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F., Schubiger P. A. (1998). \textit{11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}{doi:10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}.
\item Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997). \textit{Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(96)00246-1}{doi:10.1016/s0893-133x(96)00246-1}.
\item Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC (1996). \textit{Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.}. Molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0026-895x(25)09149-7}{doi:10.1016/s0026-895x(25)09149-7}.
\item Hanes KR (1996). \textit{Serotonin, psilocybin, and body dysmorphic disorder: a case report.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/00004714-199604000-00011}{doi:10.1097/00004714-199604000-00011}.
\item Hery F, Hamon M (1993). \textit{[Neuroleptics and serotonin].}. L'Encephale. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/7905821/}{source link}.
\item Strassman RJ (1992). \textit{Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1388647/}{source link}.
\item T. Stijve (1991). \textit{Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532101}{source link}.
\item Buckholtz NS, Zhou DF, Freedman DX, Potter WZ (1990). \textit{Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1969270/}{source link}.
\item Appel JB, Callahan PM (1989). \textit{Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(89)90041-1}{doi:10.1016/0014-2999(89)90041-1}.
\item Eivindvik K, Rasmussen KE, Sund RB (1989). \textit{Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.}. Acta pharmaceutica Nordica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2610906/}{source link}.
\item Martin WR, Sloan JW (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item Jochen Gartz (1986). \textit{Psilocybin in Mycelkulturen von Inocybe aeruginascens}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80042-7}{doi:10.1016/s0015-3796(86)80042-7}.
\item Richard Evans Schultes (1984). \textit{The genus psilocybe}. Journal of Ethnopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0378-8741(84)90031-x}{doi:10.1016/0378-8741(84)90031-x}.
\item Trulson ME, Preussler DW, Trulson VM (1984). \textit{Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)21616-0}{doi:10.1016/s0022-3565(25)21616-0}.
\item McCall RB (1982). \textit{Neurophysiological effects of hallucinogens on serotonergic neuronal systems.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/0149-7634(82)90033-1}{doi:10.1016/0149-7634(82)90033-1}.
\item Trulson ME, Heym J, Jacobs BL (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Brain research. [published; PubMed]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item Laubscher A, Pletscher A, Noll H (1981). \textit{Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)32431-6}{doi:10.1016/s0022-3565(25)32431-6}.
\item Järbe TU (1980). \textit{LDS-25 as a discriminative stimulus for response selection by pigeons.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(80)90279-8}{doi:10.1016/0091-3057(80)90279-8}.
\item McCall RB, Aghajanian GK. (1980). \textit{Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.}. Life sciences. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(80)90654-2}{doi:10.1016/0024-3205(80)90654-2}.
\item Chilton W. Scott, Bigwood Jeremy, Jensen Robert E. (1979). \textit{Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic Observations}. Journal of Psychedelic Drugs. [published; Crossref]. \href{https://doi.org/10.1080/02791072.1979.10472093}{doi:10.1080/02791072.1979.10472093}.
\item Whitaker PM, Seeman P (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Green JP, Weinstein H, Maayani S (1978). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. NIDA research monograph. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/30911/}{source link}.
\item Trulson ME, Stark AD, Jacobs BL (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item James Edward Guest (1976). \textit{Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit}. UA Campus Repository (The University of Arizona). [published; OpenAlex]. \href{http://hdl.handle.net/10150/348103}{source link}.
\item Hungen KV, Roberts S, Hill DF (1975). \textit{Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.}. Brain research. [published; PubMed]. \href{https://doi.org/10.1016/0006-8993(75)90876-8}{doi:10.1016/0006-8993(75)90876-8}.
\item Fischer R, Goldman H (1975). \textit{Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.}. Pharmakopsychiatrie, Neuro-Psychopharmakologie. [published; PubMed]. \href{https://doi.org/10.1055/s-0028-1094457}{doi:10.1055/s-0028-1094457}.
\item Steven H. Pollock (1975). \textit{The Psilocybin Mushroom Pandemic}. Journal of Psychedelic Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.1975.10472640}{doi:10.1080/02791072.1975.10472640}.
\item Aghajanian GK, Hailgler HJ (1975). \textit{Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.}. Psychopharmacology communications. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1063421/}{source link}.
\item Rech RH, Tilson HA, Marquis WJ (1975). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Advances in biochemical psychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1163377/}{source link}.
\item Hans Peter Weber, Trevor J. Petcher (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197435062}{doi:10.1002/chin.197435062}.
\item Stolk JM, Barchas JD, Goldstein M, Boggan W, Freedman DX. (1974). \textit{A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29806-8}{doi:10.1016/s0022-3565(25)29806-8}.
\item Haefely W. (1973). \textit{The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.}. Naunyn-Schmiedeberg's archives of pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00503495}{doi:10.1007/bf00503495}.
\item Dyer DC, Gant DW. (1973). \textit{Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29420-4}{doi:10.1016/s0022-3565(25)29420-4}.
\item Robert Walker, G.N. Woodruff (1972). \textit{The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons}. Comparative and General Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0010-4035(72)90039-0}{doi:10.1016/0010-4035(72)90039-0}.
\item Brown JK, Shapazian L, Griffin GD. (1971). \textit{A rapid screening procedure for some "street drugs" by thin-layer chromatography.}. Journal of chromatography. [published; Europe PMC]. \href{https://doi.org/10.1016/s0021-9673(00)92956-x}{doi:10.1016/s0021-9673(00)92956-x}.
\item Schechter MD, Rosecrans JA. (1971). \textit{Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00422707}{doi:10.1007/bf00422707}.
\item Andén NE, Corrodi H, Fuxe K. (1971). \textit{Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29027-9}{doi:10.1016/s0022-3565(25)29027-9}.
\item K. Genest, Lorna J. Lowry (1970). \textit{Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens}. Journal of Pharmacy and Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1111/j.2042-7158.1970.tb08449.x}{doi:10.1111/j.2042-7158.1970.tb08449.x}.
\item 五郎 中村 (1970). \textit{PsilocybinおよびLSDの精神身体症状におよぼす影響-1-LSDに就て}. 新潟医学会雑誌. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018192360}{source link}.
\item Richard Hill, Roland A. Fischer (1970). \textit{Psilocybin-Induced Transformations of Visual Space}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094281}{doi:10.1055/s-0028-1094281}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch9700853}{doi:10.1071/ch9700853}.
\item Martin WR, Eades CG. (1969). \textit{The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00402084}{doi:10.1007/bf00402084}.
\item Peter Gwynne, Roland Fischer, Richard Hill (1969). \textit{Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094250}{doi:10.1055/s-0028-1094250}.
\item Edward T. Uyeno (1969). \textit{Alteration of a learned response of the squirrel monkey by hallucinogens}. International Journal of Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0028-3908(69)90045-8}{doi:10.1016/0028-3908(69)90045-8}.
\item Hill RM, Fischer R, Warshay D. (1969). \textit{Effects of excitatory and tranquilizing drugs on visual perception. Spatial distortion thresholds.}. Experientia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01899105}{doi:10.1007/bf01899105}.
\item R Fischer, Diana Warshay (1968). \textit{Psilocybin-induced Autonomic, Perceptual, and Behavioral Change}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094227}{doi:10.1055/s-0028-1094227}.
\item C Schneider (1968). \textit{Behavioural Effects of some Morphine Antagonists and Hallucinogens in the Rat}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/220586a0}{doi:10.1038/220586a0}.
\item Appel JB, Freedman DX. (1968). \textit{Tolerance and cross-tolerance among psychotomimetic drugs.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401404}{doi:10.1007/bf00401404}.
\item Malcolm B. Bowers (1967). \textit{Dynamics of Psychedelic Drug Abuse}. Archives of General Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/archpsyc.1967.01730230044006}{doi:10.1001/archpsyc.1967.01730230044006}.
\item Gilmour LP, O'Brien RD (1967). \textit{Psilocybin: reaction with a fraction of rat brain.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.155.3759.207}{doi:10.1126/science.155.3759.207}.
\item Corne SJ, Pickering RW. (1966). \textit{A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401509}{doi:10.1007/bf00401509}.
\item Richard R. Heim, K. Genest, Donald W. Hughes, G. Belec (1966). \textit{Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe}. Journal of the Forensic Science Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-7368(66)70336-3}{doi:10.1016/s0015-7368(66)70336-3}.
\item Collins RL, Ordy JM, Samorajski T (1966). \textit{Psilocin: effects on behaviour and brain serotonin in mice.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/209785a0}{doi:10.1038/209785a0}.
\item Uyeno ET. (1966). \textit{Inhibition of isolation-induced attack behavior of mice by drugs.}. Journal of pharmaceutical sciences. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600550221}{doi:10.1002/jps.2600550221}.
\item Sjoberg BM, Hollister LE. (1965). \textit{The effects of psychotomimetic drugs on primary suggestibility.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00407857}{doi:10.1007/bf00407857}.
\item John C. Pollard, Leonard Uhr, Elizabeth Stein (1965). \textit{Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college students}. Medical Entomology and Zoology. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.1966.03100150141056}{doi:10.1001/jama.1966.03100150141056}.
\item LUDWIG AM, LEVINE J. (1964). \textit{PATTERNS OF HALLUCINOGENIC DRUG ABUSE.}. JAMA. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.1965.03080020020006}{doi:10.1001/jama.1965.03080020020006}.
\item TOLAN EJ, LINGL FA. (1964). \textit{"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.}. American Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.120.8.757}{doi:10.1176/ajp.120.8.757}.
\item Joseph Havens (1964). \textit{A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://doi.org/10.2307/1384511}{doi:10.2307/1384511}.
\item WOOLLEY DW, CAMPBELL NK (1962). \textit{Serotonin-like and antiserotonin properties of psilocybin and psilocin.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.136.3518.777}{doi:10.1126/science.136.3518.777}.
\item VITEK V, VOJTECHOVSKY M, GROF S (1961). \textit{[Serotonin metabolism in experimental psilocybin psychosis].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13926289/}{source link}.
\item F. Silva, R.G. Heath, Thomas Rafferty, Robert A. Johnson, William R. Robinson (1960). \textit{Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteers}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-440x(60)80060-0}{doi:10.1016/s0010-440x(60)80060-0}.
\item GESSNER PK, KHAIRALLAH PA, McISAAC WM, PAGE IH (1960). \textit{The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)25873-6}{doi:10.1016/s0022-3565(25)25873-6}.
\item S MALITZ, H ESECOVER, B WILKENS, P HOCH (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects}. Corrosion Science. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-938x(60)80004-2}{doi:10.1016/s0010-938x(60)80004-2}.
\item Harold A. Abramson, Anabela P. Rolo, B. Sklarofsky, J. Stache (1960). \textit{Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin}. The Journal of Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/00223980.1960.9916396}{doi:10.1080/00223980.1960.9916396}.
\end{enumerate}
\end{document}
